메뉴 건너뛰기




Volumn , Issue , 2009, Pages 1275-1286

T-Cell Depletion to Prevent Graft-versus-Host Disease

Author keywords

Efforts to reduce relapse after T cell depleted HCT; Haploid identical donor transplantation; Immune reconstitution and infectious complications; Organ dysfunction; T cell depletion to prevent graft versus host disease; TCD and reduced intensity transplantation

Indexed keywords


EID: 84876407279     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444303537.ch85     Document Type: Chapter
Times cited : (1)

References (210)
  • 1
    • 0025100777 scopus 로고
    • Graftversus-leukemia reactions after bone marrow transplantation
    • Horowitz MM, Gale RP, Sondel PM et al. Graftversus-leukemia reactions after bone marrow transplantation. Blood 1990; 75: 555-62.
    • (1990) Blood , vol.75 , pp. 555-562
    • Horowitz, M.M.1    Gale, R.P.2    Sondel, P.M.3
  • 2
    • 0033168009 scopus 로고    scopus 로고
    • Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry
    • Socie G, Stone JV, Wingard JR et al. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. N Engl J Med 1999; 341: 14-21.
    • (1999) N Engl J Med , vol.341 , pp. 14-21
    • Socie, G.1    Stone, J.V.2    Wingard, J.R.3
  • 3
    • 0035760863 scopus 로고    scopus 로고
    • The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation
    • Ho V, Soiffer RJ. The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation. Blood 2001; 98: 3192-204.
    • (2001) Blood , vol.98 , pp. 3192-3204
    • Ho, V.1    Soiffer, R.J.2
  • 4
    • 0022495149 scopus 로고
    • Depletion of donor lymphocytes by counterflow centrifugation successfully prevents acute graftversus-host disease in matched allogeneic marrow transplantation
    • De Witte T, Hoogenhout J, de Pauw B et al. Depletion of donor lymphocytes by counterflow centrifugation successfully prevents acute graftversus-host disease in matched allogeneic marrow transplantation. Blood 1986; 67: 1302-8.
    • (1986) Blood , vol.67 , pp. 1302-1308
    • De Witte, T.1    Hoogenhout, J.2    de Pauw, B.3
  • 5
    • 0021345180 scopus 로고
    • Depletion of T lymphocytes in donor marrow prevents significant graft-versus-host disease in matched allogeneic leukemic marrow transplant recipients
    • Prentice HG, Janossy G, Price-Jones L et al. Depletion of T lymphocytes in donor marrow prevents significant graft-versus-host disease in matched allogeneic leukemic marrow transplant recipients. Lancet 1984; 1: 472-6.
    • (1984) Lancet , vol.1 , pp. 472-476
    • Prentice, H.G.1    Janossy, G.2    Price-Jones, L.3
  • 6
    • 0022650754 scopus 로고
    • Development of a simplified counterflow centrifugation elutriation procedure for depletion of lymphocytes from human bone marrow
    • Noga SJ, Donnenberg AD, Schwartz CL et al. Development of a simplified counterflow centrifugation elutriation procedure for depletion of lymphocytes from human bone marrow. Transplantation 1986; 41: 220-8.
    • (1986) Transplantation , vol.41 , pp. 220-228
    • Noga, S.J.1    Donnenberg, A.D.2    Schwartz, C.L.3
  • 7
    • 0021227678 scopus 로고
    • Elimination of graft-versus-host disease by in vitro depletion of alloreactive lymphocytes with a monoclonal rat anti-human lymphocyte antibody (Campath-1)
    • Waldmann HG, Polliak A, Hale G et al. Elimination of graft-versus-host disease by in vitro depletion of alloreactive lymphocytes with a monoclonal rat anti-human lymphocyte antibody (Campath-1). Lancet 1984; 2: 483-6.
    • (1984) Lancet , vol.2 , pp. 483-486
    • Waldmann, H.G.1    Polliak, A.2    Hale, G.3
  • 8
    • 0029923272 scopus 로고    scopus 로고
    • Combined in vitro and in vivo T lymphocyte depletion for the control of graft-versus-host disease following haploidentical marrow transplant
    • Henslee-Downey PJ, Parrish RS, MacDonald JS et al. Combined in vitro and in vivo T lymphocyte depletion for the control of graft-versus-host disease following haploidentical marrow transplant. Transplantation 1996; 61: 738-45.
    • (1996) Transplantation , vol.61 , pp. 738-745
    • Henslee-Downey, P.J.1    Parrish, R.S.2    MacDonald, J.S.3
  • 9
    • 0033949148 scopus 로고    scopus 로고
    • CD52 antibodies for prevention of graft-versus-host disease and graft rejection following transplantation of allogeneic peripheral blood stem cells
    • Hale G, Jacobs P, Wood L et al. CD52 antibodies for prevention of graft-versus-host disease and graft rejection following transplantation of allogeneic peripheral blood stem cells. Bone Marrow Transplant 2000; 26: 69-76.
    • (2000) Bone Marrow Transplant , vol.26 , pp. 69-76
    • Hale, G.1    Jacobs, P.2    Wood, L.3
  • 10
    • 0028838033 scopus 로고
    • G-CSFmobilized peripheral blood progenitor cells for allogeneic transplantation: comparison of T cell depletion strategies using different CD34+ selection systems or Campath-1
    • Dreger P, Viehmann K, Steinmann J et al. G-CSFmobilized peripheral blood progenitor cells for allogeneic transplantation: comparison of T cell depletion strategies using different CD34+ selection systems or Campath-1. Exp Hematol 1995; 23: 147-54.
    • (1995) Exp Hematol , vol.23 , pp. 147-154
    • Dreger, P.1    Viehmann, K.2    Steinmann, J.3
  • 11
    • 0025127674 scopus 로고
    • T cell depletion with anti-CD5 immunotoxin in histocompatible bone marrow transplantation
    • Filipovich AH, Vallera D, McGlave P et al. T cell depletion with anti-CD5 immunotoxin in histocompatible bone marrow transplantation. Transplantation 1990; 50: 410-14.
    • (1990) Transplantation , vol.50 , pp. 410-414
    • Filipovich, A.H.1    Vallera, D.2    McGlave, P.3
  • 12
    • 0022461904 scopus 로고
    • Graft rejection following HLA matched T-lymphocyte depleted bone marrow transplantation
    • Patterson J, Prentice HG, Brenner MK et al. Graft rejection following HLA matched T-lymphocyte depleted bone marrow transplantation. Br J Haematol 1986; 63: 221-30.
    • (1986) Br J Haematol , vol.63 , pp. 221-230
    • Patterson, J.1    Prentice, H.G.2    Brenner, M.K.3
  • 13
    • 0022620989 scopus 로고
    • Treatment of donor bone marrow with monoclonal anti-T-cell antibody and complement for the prevention of graft-versus-host disease. A prospective, randomized, double-blind trial
    • Mitsuyasu RT, Champlin RE, Gale RP et al. Treatment of donor bone marrow with monoclonal anti-T-cell antibody and complement for the prevention of graft-versus-host disease. A prospective, randomized, double-blind trial. Ann Intern Med 1986; 105: 20-6.
    • (1986) Ann Intern Med , vol.105 , pp. 20-26
    • Mitsuyasu, R.T.1    Champlin, R.E.2    Gale, R.P.3
  • 14
    • 0021968318 scopus 로고
    • Transplantation of marrow-depleted T cells by soybean lectin agglutination and E-rosette depletion: major histocompatibility complex-related graft resistance in leukemic transplant patients
    • O'Reilly R, Collins NH, Kernan N et al. Transplantation of marrow-depleted T cells by soybean lectin agglutination and E-rosette depletion: major histocompatibility complex-related graft resistance in leukemic transplant patients. Transplant Proc 1985; 17: 455-62.
    • (1985) Transplant Proc , vol.17 , pp. 455-462
    • O'Reilly, R.1    Collins, N.H.2    Kernan, N.3
  • 15
    • 0023748386 scopus 로고
    • Epstein-Barr virus lymphoproliferation after bone marrow transplantation
    • Zutter MM, Martin PJ, Sale GE et al. Epstein-Barr virus lymphoproliferation after bone marrow transplantation. Blood 1988; 72: 520-9.
    • (1988) Blood , vol.72 , pp. 520-529
    • Zutter, M.M.1    Martin, P.J.2    Sale, G.E.3
  • 16
    • 0023946601 scopus 로고
    • Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation
    • Shapiro RS, McClain K, Frizzera G et al. Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation. Blood 1988; 71: 1234-43.
    • (1988) Blood , vol.71 , pp. 1234-1243
    • Shapiro, R.S.1    McClain, K.2    Frizzera, G.3
  • 17
    • 9444232751 scopus 로고    scopus 로고
    • Risk factors for developing EBV-related B cell lymphoproliferative disorders (BLPD) after non-HLA-identical BMT in children
    • Gerritsen EJ, Stam ED, Hermans J et al. Risk factors for developing EBV-related B cell lymphoproliferative disorders (BLPD) after non-HLA-identical BMT in children. Bone Marrow Transplant 1996; 18: 377-82.
    • (1996) Bone Marrow Transplant , vol.18 , pp. 377-382
    • Gerritsen, E.J.1    Stam, E.D.2    Hermans, J.3
  • 18
    • 0026049124 scopus 로고
    • T-cell depletion of HLA-identical transplants in leukemia
    • Marmont A, Horowitz MM, Gale RP et al. T-cell depletion of HLA-identical transplants in leukemia. Blood 1991; 78: 2120-30.
    • (1991) Blood , vol.78 , pp. 2120-2130
    • Marmont, A.1    Horowitz, M.M.2    Gale, R.P.3
  • 19
    • 0023940821 scopus 로고
    • Bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: importance of a graft-versus-leukaemia effect
    • Apperley JF, Mauro FR, Goldman JM et al. Bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: importance of a graft-versus-leukaemia effect. Br J Haematol 1988; 69: 239-45.
    • (1988) Br J Haematol , vol.69 , pp. 239-245
    • Apperley, J.F.1    Mauro, F.R.2    Goldman, J.M.3
  • 20
    • 0023690307 scopus 로고
    • Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion
    • Goldman JM, Gale RP, Horowitz MM et al. Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion. Ann Intern Med 1988; 108: 806-14.
    • (1988) Ann Intern Med , vol.108 , pp. 806-814
    • Goldman, J.M.1    Gale, R.P.2    Horowitz, M.M.3
  • 21
    • 23944436856 scopus 로고    scopus 로고
    • Effect of graft-versus-host disease prophylaxis on 3-year disease-free survival in recipients of unrelated donor bone marrow (T-cell Depletion Trial): a multi-centre, randomised phase II-III trial
    • Wagner JE, Thompson JS, Carter SL, Kernan NA. Effect of graft-versus-host disease prophylaxis on 3-year disease-free survival in recipients of unrelated donor bone marrow (T-cell Depletion Trial): a multi-centre, randomised phase II-III trial. Lancet 2005; 366: 733-41.
    • (2005) Lancet , vol.366 , pp. 733-741
    • Wagner, J.E.1    Thompson, J.S.2    Carter, S.L.3    Kernan, N.A.4
  • 22
    • 44049099424 scopus 로고
    • The immunological and histological responses following spleen treatment in irradiated mice
    • Michael JS, Holmes BE, editors, Edinburgh: Oliver & Boyd
    • Barnes DWH, Loutit JF. The immunological and histological responses following spleen treatment in irradiated mice: In: Michael JS, Holmes BE, editors. Progress in Radiobiology. Edinburgh: Oliver & Boyd; 1954. pp. 291-300.
    • (1954) Progress in Radiobiology , pp. 291-300
    • Barnes, D.W.H.1    Loutit, J.F.2
  • 23
    • 0242724031 scopus 로고
    • Preclusion of secondary phase of irradiation syndrome by inoculation of hematopoietic tissue following lethal total body X-irradiation
    • Uphoff DE. Preclusion of secondary phase of irradiation syndrome by inoculation of hematopoietic tissue following lethal total body X-irradiation. J Natl Cancer Inst 1958; 20: 625-31.
    • (1958) J Natl Cancer Inst , vol.20 , pp. 625-631
    • Uphoff, D.E.1
  • 24
    • 0014683046 scopus 로고
    • Graft versus host inhibition: fetal liver and thymus cells minimize secondary disease
    • Bortin MM, Saltzstein EC. Graft versus host inhibition: fetal liver and thymus cells minimize secondary disease. Science 1969; 164: 316-19.
    • (1969) Science , vol.164 , pp. 316-319
    • Bortin, M.M.1    Saltzstein, E.C.2
  • 25
    • 0014311463 scopus 로고
    • The selective elimination of immunologically competent cells from bone marrow and lymphatic cell mixtures. II. Mouse spleen cell fractionation on a discontinuous albumin gradient
    • Dicke KA, van Hoot JIM, van Bekkum DW. The selective elimination of immunologically competent cells from bone marrow and lymphatic cell mixtures. II. Mouse spleen cell fractionation on a discontinuous albumin gradient. Transplantation 1968; 6: 562-8.
    • (1968) Transplantation , vol.6 , pp. 562-568
    • Dicke, K.A.1    van Hoot, J.I.M.2    van Bekkum, D.W.3
  • 26
    • 1942421930 scopus 로고
    • Hematopoietic stem cell transplantation using mouse bone marrow and spleen cells fractionated by lectins
    • Reisner Y, Itzicovitch L, Meshorer A, Sharon N. Hematopoietic stem cell transplantation using mouse bone marrow and spleen cells fractionated by lectins. Proc Natl Acad Sci U S A 1978; 75: 2933-6.
    • (1978) Proc Natl Acad Sci U S A , vol.75 , pp. 2933-2936
    • Reisner, Y.1    Itzicovitch, L.2    Meshorer, A.3    Sharon, N.4
  • 27
    • 0018420087 scopus 로고
    • GVHD suppression by incubation of bone marrow grafts with anti-T-cell globulin: effect in canine model and application to clinical bone marrow transplantation
    • Rodt H, Kolb HJ, Netzel B et al. GVHD suppression by incubation of bone marrow grafts with anti-T-cell globulin: effect in canine model and application to clinical bone marrow transplantation. Transplant Proc 1979; 11: 962-6.
    • (1979) Transplant Proc , vol.11 , pp. 962-966
    • Rodt, H.1    Kolb, H.J.2    Netzel, B.3
  • 28
    • 0016007583 scopus 로고
    • Antilymphocyte antibodies and marrow transplantation. III. Effect of heterologous anti-brain antibodies on acute secondary disease in mice
    • Rodt H, Theirfelder S, Eulitz M. Antilymphocyte antibodies and marrow transplantation. III. Effect of heterologous anti-brain antibodies on acute secondary disease in mice. Eur J Immunol 1974; 4: 15-19.
    • (1974) Eur J Immunol , vol.4 , pp. 15-19
    • Rodt, H.1    Theirfelder, S.2    Eulitz, M.3
  • 29
    • 0015593069 scopus 로고
    • Prevention of acute graftversus-host (GVH) mortality with spleen-absorbed antithymocyte globulin (ATG)
    • Trentin JJ, Judd KP. Prevention of acute graftversus-host (GVH) mortality with spleen-absorbed antithymocyte globulin (ATG). Transplant Proc 1973; 5: 865-8.
    • (1973) Transplant Proc , vol.5 , pp. 865-868
    • Trentin, J.J.1    Judd, K.P.2
  • 30
    • 0018771463 scopus 로고
    • Antilymphocyte antibodies and marrow transplantation. VI. Graft-versus-host tolerance in DLA-incompatible dogs after in vitro treatment of bone marrow absorbed with antithymocyte globulin
    • Kolb HJ, Rieder I, Rodt H et al. Antilymphocyte antibodies and marrow transplantation. VI. Graft-versus-host tolerance in DLA-incompatible dogs after in vitro treatment of bone marrow absorbed with antithymocyte globulin. Transplantation 1979; 27: 242-5.
    • (1979) Transplantation , vol.27 , pp. 242-245
    • Kolb, H.J.1    Rieder, I.2    Rodt, H.3
  • 31
    • 0018257740 scopus 로고
    • Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow
    • Korngold R, Sprent J. Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow. J Exp Med 1978; 148: 1687-98.
    • (1978) J Exp Med , vol.148 , pp. 1687-1698
    • Korngold, R.1    Sprent, J.2
  • 32
    • 0019522465 scopus 로고
    • Bone marrow transplantation across major histocompatibility barriers in mice
    • Vallera DA, Soderling CCB, Carlson GJ, Kersey JH. Bone marrow transplantation across major histocompatibility barriers in mice. Transplantation 1981; 31: 218-22.
    • (1981) Transplantation , vol.31 , pp. 218-222
    • Vallera, D.A.1    Soderling, C.C.B.2    Carlson, G.J.3    Kersey, J.H.4
  • 33
    • 0022000530 scopus 로고
    • Quantitative assays for detection of residual T cells in T-depleted human marrow
    • Martin PJ, Hansen JA. Quantitative assays for detection of residual T cells in T-depleted human marrow. Blood 1985; 65: 1134-40.
    • (1985) Blood , vol.65 , pp. 1134-1140
    • Martin, P.J.1    Hansen, J.A.2
  • 34
    • 0022521334 scopus 로고
    • Clonable T lymphocytes in T-cell depleted bone marrow transplants correlate with development of graftversus-host disease
    • Kernan NA, Collins NH, Juliano L et al. Clonable T lymphocytes in T-cell depleted bone marrow transplants correlate with development of graftversus-host disease. Blood 1986; 68: 770-3.
    • (1986) Blood , vol.68 , pp. 770-773
    • Kernan, N.A.1    Collins, N.H.2    Juliano, L.3
  • 35
    • 0023796796 scopus 로고
    • Lymphocyte depletion of donor bone marrow by counterflow centrifugal elutriation: results of a phase I clinical trial
    • Wagner JE, Donnenberg AD, Noga SJ et al. Lymphocyte depletion of donor bone marrow by counterflow centrifugal elutriation: results of a phase I clinical trial. Blood 1988; 72: 1168-76.
    • (1988) Blood , vol.72 , pp. 1168-1176
    • Wagner, J.E.1    Donnenberg, A.D.2    Noga, S.J.3
  • 36
    • 0022855253 scopus 로고
    • Graft-versus-host disease following transplantation of "one log" versus "two log" Tlymphocyte depleted bone marrow from HLAidentical donors
    • Lowenberg B, Wagemaker E, van Bekkum DW et al. Graft-versus-host disease following transplantation of "one log" versus "two log" Tlymphocyte depleted bone marrow from HLAidentical donors. Bone Marrow Transplant 1986; 1: 133-40.
    • (1986) Bone Marrow Transplant , vol.1 , pp. 133-140
    • Lowenberg, B.1    Wagemaker, E.2    van Bekkum, D.W.3
  • 37
    • 0035863919 scopus 로고    scopus 로고
    • The number of donor CD3(+) cells is the most important factor for graft failure after allogeneic transplantation of CD34(+) selected cells from peripheral blood from HLA-identical siblings
    • Urbano-Ispizua A, Rozman C, Pimentel P et al. The number of donor CD3(+) cells is the most important factor for graft failure after allogeneic transplantation of CD34(+) selected cells from peripheral blood from HLA-identical siblings. Blood 2001; 97: 383-7.
    • (2001) Blood , vol.97 , pp. 383-387
    • Urbano-Ispizua, A.1    Rozman, C.2    Pimentel, P.3
  • 38
    • 0037100545 scopus 로고    scopus 로고
    • Risk factors for acute graft-versus-host disease in patients undergoing transplantation with CD34+ selected blood cells from HLA-identical siblings
    • Urbano-Ispizua A, Rozman C, Pimentel P et al. Risk factors for acute graft-versus-host disease in patients undergoing transplantation with CD34+ selected blood cells from HLA-identical siblings. Blood 2002; 100: 724-7.
    • (2002) Blood , vol.100 , pp. 724-727
    • Urbano-Ispizua, A.1    Rozman, C.2    Pimentel, P.3
  • 39
    • 0034099070 scopus 로고    scopus 로고
    • CD34+ cell dose predicts relapse and survival after T-celldepleted HLA-identical haematopoietic stem cell transplantation (HSCT) for haematological malignancies
    • Bahceci E, Read EJ, Leitman S et al. CD34+ cell dose predicts relapse and survival after T-celldepleted HLA-identical haematopoietic stem cell transplantation (HSCT) for haematological malignancies. Br J Haematol 2000; 108: 408-14.
    • (2000) Br J Haematol , vol.108 , pp. 408-414
    • Bahceci, E.1    Read, E.J.2    Leitman, S.3
  • 40
    • 0035761435 scopus 로고    scopus 로고
    • CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen-identical sibling transplantation
    • Zaucha JM, Gooley T, Bensinger WI et al. CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen-identical sibling transplantation. Blood 2001; 98: 3221-7.
    • (2001) Blood , vol.98 , pp. 3221-3227
    • Zaucha, J.M.1    Gooley, T.2    Bensinger, W.I.3
  • 41
    • 0035889140 scopus 로고    scopus 로고
    • Allogeneic transplantation of CD34(+) selected cells from peripheral blood from human leukocyte antigen-identical siblings: detrimental effect of a high number of donor CD34(+) cells
    • Urbano-Ispizua A, Carreras E, Marin P et al. Allogeneic transplantation of CD34(+) selected cells from peripheral blood from human leukocyte antigen-identical siblings: detrimental effect of a high number of donor CD34(+) cells. Blood 2001; 98: 2352-7.
    • (2001) Blood , vol.98 , pp. 2352-2357
    • Urbano-Ispizua, A.1    Carreras, E.2    Marin, P.3
  • 42
    • 0037930786 scopus 로고    scopus 로고
    • Decreased treatment failure in recipients of HLA-identical bone marrow or peripheral blood stem cell transplants with high CD34 cell doses
    • Ringden O, Barrett AJ, Zhang MJ et al. Decreased treatment failure in recipients of HLA-identical bone marrow or peripheral blood stem cell transplants with high CD34 cell doses. Br J Haematol 2003; 121: 874-85.
    • (2003) Br J Haematol , vol.121 , pp. 874-885
    • Ringden, O.1    Barrett, A.J.2    Zhang, M.J.3
  • 43
    • 34347371779 scopus 로고    scopus 로고
    • CTLA-4 polymorphisms and clinical outcome after allogeneic stem cell transplantation from HLA-identical sibling donors
    • Perez-Garcia A, De la Camara R, Roman-Gomez J et al. CTLA-4 polymorphisms and clinical outcome after allogeneic stem cell transplantation from HLA-identical sibling donors. Blood 2007; 110: 461-7.
    • (2007) Blood , vol.110 , pp. 461-467
    • Perez-Garcia, A.1    De la Camara, R.2    Roman-Gomez, J.3
  • 44
    • 0033485649 scopus 로고    scopus 로고
    • Recipient tumor necrosis factor-alpha and interleukin-10 gene polymorphisms associate with early mortality and acute graft-versus-host disease severity in HLA-matched sibling bone marrow transplants
    • Cavet J, Middleton PG, Segall M et al. Recipient tumor necrosis factor-alpha and interleukin-10 gene polymorphisms associate with early mortality and acute graft-versus-host disease severity in HLA-matched sibling bone marrow transplants. Blood 1999; 94: 3941-6.
    • (1999) Blood , vol.94 , pp. 3941-3946
    • Cavet, J.1    Middleton, P.G.2    Segall, M.3
  • 45
    • 84983719872 scopus 로고    scopus 로고
    • Relation of an interleukin-10 promoter polymorphism to graftversus-host disease and survival after hematopoietic-cell transplantation
    • Lin M, Storer B, Martin PJ et al. Relation of an interleukin-10 promoter polymorphism to graftversus-host disease and survival after hematopoietic-cell transplantation. N Engl J Med 2003; 349: 2201-10.
    • (2003) N Engl J Med , vol.349 , pp. 2201-2210
    • Lin, M.1    Storer, B.2    Martin, P.J.3
  • 46
    • 33846390689 scopus 로고    scopus 로고
    • Mapping of susceptibility and protective loci for acute GVHD in unrelated HLA-matched bone marrow transplantation donors and recipients using 155 microsatellite markers on chromosome 22
    • Kikuchi T, Naruse TK, Onizuka M et al. Mapping of susceptibility and protective loci for acute GVHD in unrelated HLA-matched bone marrow transplantation donors and recipients using 155 microsatellite markers on chromosome 22. Immunogenetics 2007; 59: 99-108.
    • (2007) Immunogenetics , vol.59 , pp. 99-108
    • Kikuchi, T.1    Naruse, T.K.2    Onizuka, M.3
  • 47
    • 13344278000 scopus 로고    scopus 로고
    • Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation
    • Goulmy E, Schipper R, Pool J et al. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N Engl J Med 1996; 334: 281-5.
    • (1996) N Engl J Med , vol.334 , pp. 281-285
    • Goulmy, E.1    Schipper, R.2    Pool, J.3
  • 48
    • 0035892107 scopus 로고    scopus 로고
    • Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO)
    • Bacigalupo A, Lamparelli T, Bruzzi P et al. Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO). Blood 2001; 98: 2942-7.
    • (2001) Blood , vol.98 , pp. 2942-2947
    • Bacigalupo, A.1    Lamparelli, T.2    Bruzzi, P.3
  • 49
    • 18844467941 scopus 로고    scopus 로고
    • T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities
    • Champlin RE, Passweg JR, Zhang MJ et al. T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities. Blood 2000; 95: 3996-4003.
    • (2000) Blood , vol.95 , pp. 3996-4003
    • Champlin, R.E.1    Passweg, J.R.2    Zhang, M.J.3
  • 50
    • 0242557055 scopus 로고    scopus 로고
    • Posthematopoietic cell transplantation control of graft-versus-host disease by donor CD4+25+ T cells to allow an effective graft-versus-leukemia response
    • Jones SC, Murphy GF, Korngold R. Posthematopoietic cell transplantation control of graft-versus-host disease by donor CD4+25+ T cells to allow an effective graft-versus-leukemia response. Biol Blood Marrow Transplant 2003; 9: 243-56.
    • (2003) Biol Blood Marrow Transplant , vol.9 , pp. 243-256
    • Jones, S.C.1    Murphy, G.F.2    Korngold, R.3
  • 51
    • 9444280125 scopus 로고    scopus 로고
    • L-Selectin(hi) but not the L-selectin(lo) CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection
    • Taylor PA, Panoskaltsis-Mortari A, Swedin JM et al. L-Selectin(hi) but not the L-selectin(lo) CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection. Blood 2004; 104: 3804-12.
    • (2004) Blood , vol.104 , pp. 3804-3812
    • Taylor, P.A.1    Panoskaltsis-Mortari, A.2    Swedin, J.M.3
  • 52
    • 33947203388 scopus 로고    scopus 로고
    • In vivo dynamics of regulatory T-cell trafficking and survival predict effective strategies to control graft-versus-host disease following allogeneic transplantation
    • Nguyen VH, Zeiser R, Dasilva DL et al. In vivo dynamics of regulatory T-cell trafficking and survival predict effective strategies to control graft-versus-host disease following allogeneic transplantation. Blood 2007; 109: 2649-56.
    • (2007) Blood , vol.109 , pp. 2649-2656
    • Nguyen, V.H.1    Zeiser, R.2    Dasilva, D.L.3
  • 53
    • 0020061303 scopus 로고
    • Pretreatment of donor bone marrow with monoclonal antibody OKT3 for prevention of acute graft versus host disease in allogeneic histocompatible bone marrow transplantation
    • Filipovich AH, McGlave PB, Ramsay NKC et al. Pretreatment of donor bone marrow with monoclonal antibody OKT3 for prevention of acute graft versus host disease in allogeneic histocompatible bone marrow transplantation. Lancet 1982; 1: 1266-9.
    • (1982) Lancet , vol.1 , pp. 1266-1269
    • Filipovich, A.H.1    McGlave, P.B.2    Ramsay, N.K.C.3
  • 54
    • 0021322965 scopus 로고
    • Preincubation of donor bone marrow cells with a combination of murine monoclonal anti-T-cell antibodies without complement does not prevent graftversus-host disease after allogeneic marrow transplantation
    • Martin PJ, Hansen JA, Thomas ED. Preincubation of donor bone marrow cells with a combination of murine monoclonal anti-T-cell antibodies without complement does not prevent graftversus-host disease after allogeneic marrow transplantation. J Clin Immunol 1984; 4: 18-22.
    • (1984) J Clin Immunol , vol.4 , pp. 18-22
    • Martin, P.J.1    Hansen, J.A.2    Thomas, E.D.3
  • 55
    • 0021984561 scopus 로고
    • Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts
    • Martin PJ, Hansen JA, Buckner CD et al. Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts. Blood 1985; 66: 664-72.
    • (1985) Blood , vol.66 , pp. 664-672
    • Martin, P.J.1    Hansen, J.A.2    Buckner, C.D.3
  • 56
    • 0021999060 scopus 로고
    • Clinical trial depleting T lymphocytes from donor marrow for matched and mismatched allogeneic bone marrow transplants
    • Trigg ME, Billing R, Sondel PM et al. Clinical trial depleting T lymphocytes from donor marrow for matched and mismatched allogeneic bone marrow transplants. Cancer Treat Rep 1985; 69: 377-86.
    • (1985) Cancer Treat Rep , vol.69 , pp. 377-386
    • Trigg, M.E.1    Billing, R.2    Sondel, P.M.3
  • 57
    • 0021910077 scopus 로고
    • Removal of marrow T cells with OKT3-OKT11 monoclonal antibodies and complement to prevent graftversus-host disease
    • Herve P, Flesch M, Cahn JY et al. Removal of marrow T cells with OKT3-OKT11 monoclonal antibodies and complement to prevent graftversus-host disease. Transplantation 1985; 39: 138-43.
    • (1985) Transplantation , vol.39 , pp. 138-143
    • Herve, P.1    Flesch, M.2    Cahn, J.Y.3
  • 58
    • 0023924847 scopus 로고
    • T-cell depletion with Campath-1 in allogeneic bone marrow transplantation
    • Hale G, Cobbold S, Waldmann H. T-cell depletion with Campath-1 in allogeneic bone marrow transplantation. Transplantation 1988; 45: 753-9.
    • (1988) Transplantation , vol.45 , pp. 753-759
    • Hale, G.1    Cobbold, S.2    Waldmann, H.3
  • 59
    • 0026045680 scopus 로고
    • Selective depletion of bone marrow T lymphocytes with anti-CD5 monoclonal antibodies: effective prophylaxis for graft-versus-host disease in patients with hematologic malignancies
    • Antin JH, Bierer BE, Smith BR et al. Selective depletion of bone marrow T lymphocytes with anti-CD5 monoclonal antibodies: effective prophylaxis for graft-versus-host disease in patients with hematologic malignancies. Blood 1991; 78: 2139-49.
    • (1991) Blood , vol.78 , pp. 2139-2149
    • Antin, J.H.1    Bierer, B.E.2    Smith, B.R.3
  • 60
    • 0026773113 scopus 로고
    • Prevention of graft-versus-host disease by selective depletion of CD6-positive T lymphocytes from donor bone marrow
    • Soiffer RJ, Murray C, Mauch P et al. Prevention of graft-versus-host disease by selective depletion of CD6-positive T lymphocytes from donor bone marrow. J Clin Oncol 1992; 10: 1191-2000.
    • (1992) J Clin Oncol , vol.10 , pp. 1191-2000
    • Soiffer, R.J.1    Murray, C.2    Mauch, P.3
  • 61
    • 0025324988 scopus 로고
    • Selective depletion of CD8+ T lymphocytes for prevention of graft-versus-host disease after allogeneic bone marrow transplantation
    • Champlin R, Ho W, Gajewski J et al. Selective depletion of CD8+ T lymphocytes for prevention of graft-versus-host disease after allogeneic bone marrow transplantation. Blood 1990; 76: 418-23.
    • (1990) Blood , vol.76 , pp. 418-423
    • Champlin, R.1    Ho, W.2    Gajewski, J.3
  • 62
    • 0028929673 scopus 로고
    • Selective T cell depletion with CD8-conjugated magnetic beads in the prevention of graft-versus-host disease after allogeneic bone marrow transplantation
    • Jansen J, Hanks S, Akard L et al. Selective T cell depletion with CD8-conjugated magnetic beads in the prevention of graft-versus-host disease after allogeneic bone marrow transplantation. Bone Marrow Transplant 1995; 15: 271-8.
    • (1995) Bone Marrow Transplant , vol.15 , pp. 271-278
    • Jansen, J.1    Hanks, S.2    Akard, L.3
  • 63
    • 0028054895 scopus 로고
    • Selective depletion of CD8+ cells for prevention of graft-versus-host disease after bone marrow transplantation. A randomized controlled trial
    • Nimer SD, Giorgi J, Gajewski JL et al. Selective depletion of CD8+ cells for prevention of graft-versus-host disease after bone marrow transplantation. A randomized controlled trial. Transplantation 1994; 57: 82-7.
    • (1994) Transplantation , vol.57 , pp. 82-87
    • Nimer, S.D.1    Giorgi, J.2    Gajewski, J.L.3
  • 64
    • 0026683644 scopus 로고
    • T-cell-depleted allogeneic bone marrow transplantation in adults with acute nonlymphocytic leukemia in first remission
    • Young JW, Papadopoulos EB, Cunningham I et al. T-cell-depleted allogeneic bone marrow transplantation in adults with acute nonlymphocytic leukemia in first remission. Blood 1992; 79: 3380-7.
    • (1992) Blood , vol.79 , pp. 3380-3387
    • Young, J.W.1    Papadopoulos, E.B.2    Cunningham, I.3
  • 65
    • 0029945209 scopus 로고    scopus 로고
    • Transplantation of allogeneic CD34+ blood cells
    • Link H, Arseniev L, Bahre O et al. Transplantation of allogeneic CD34+ blood cells. Blood 1996; 87: 4903-9.
    • (1996) Blood , vol.87 , pp. 4903-4909
    • Link, H.1    Arseniev, L.2    Bahre, O.3
  • 66
    • 10544235444 scopus 로고    scopus 로고
    • Transplantation of allogeneic CD34+ peripheral blood stem cells in patients with advanced hematologic malignancy
    • Bensinger WI, Buckner CD, Shannon-Dorcy K et al. Transplantation of allogeneic CD34+ peripheral blood stem cells in patients with advanced hematologic malignancy. Blood 1996; 88: 4132-8.
    • (1996) Blood , vol.88 , pp. 4132-4138
    • Bensinger, W.I.1    Buckner, C.D.2    Shannon-Dorcy, K.3
  • 67
    • 0031719315 scopus 로고    scopus 로고
    • Allogeneic transplantation of selected CD34+ cells from peripheral blood: experience of 62 cases using immunoadsorption or immunomagnetic technique. Spanish Group of Allo-PBT
    • Urbano-Ispizua A, Solano C, Brunet S et al. Allogeneic transplantation of selected CD34+ cells from peripheral blood: experience of 62 cases using immunoadsorption or immunomagnetic technique. Spanish Group of Allo-PBT. Bone Marrow Transplant 1998; 22: 519-25.
    • (1998) Bone Marrow Transplant , vol.22 , pp. 519-525
    • Urbano-Ispizua, A.1    Solano, C.2    Brunet, S.3
  • 68
    • 0033948934 scopus 로고    scopus 로고
    • Allogeneic peripheral blood stem cell transplantation following CD34+ enrichment by density gradient separation
    • Vij R, Brown R, Shenoy S et al. Allogeneic peripheral blood stem cell transplantation following CD34+ enrichment by density gradient separation. Bone Marrow Transplant 2000; 25: 1223-8.
    • (2000) Bone Marrow Transplant , vol.25 , pp. 1223-1228
    • Vij, R.1    Brown, R.2    Shenoy, S.3
  • 69
    • 0035556064 scopus 로고    scopus 로고
    • CD34 selection using three immunoselection devices: comparison of T-cell depleted allografts
    • O'Donnell PV, Myers B, Edwards J et al. CD34 selection using three immunoselection devices: comparison of T-cell depleted allografts. Cytotherapy 2001; 3: 483-8.
    • (2001) Cytotherapy , vol.3 , pp. 483-488
    • O'Donnell, P.V.1    Myers, B.2    Edwards, J.3
  • 70
    • 0028179358 scopus 로고
    • Effect of T-cell depletion as graft-versus-host disease prophylaxis on engraftment, relapse, and disease-free survival in unrelated marrow transplantation for chronic myelogenous leukemia
    • Drobyski WR, Ash RC, Casper JT et al. Effect of T-cell depletion as graft-versus-host disease prophylaxis on engraftment, relapse, and disease-free survival in unrelated marrow transplantation for chronic myelogenous leukemia. Blood 1994; 83: 1980-7.
    • (1994) Blood , vol.83 , pp. 1980-1987
    • Drobyski, W.R.1    Ash, R.C.2    Casper, J.T.3
  • 71
    • 0033655656 scopus 로고    scopus 로고
    • T celldepleted unrelated donor bone marrow transplantation for acute myeloid leukemia
    • Marks DI, Bird JM, Vettenranta K et al. T celldepleted unrelated donor bone marrow transplantation for acute myeloid leukemia. Biol Blood Marrow Transplant 2000; 6: 646-53.
    • (2000) Biol Blood Marrow Transplant , vol.6 , pp. 646-653
    • Marks, D.I.1    Bird, J.M.2    Vettenranta, K.3
  • 72
    • 0035865161 scopus 로고    scopus 로고
    • CD6+ Donor marrow T-cell depletion as the sole form of graftversus-host disease prophylaxis in patients undergoing allogeneic bone marrow transplant from unrelated donors
    • Soiffer RJ, Weller E, Alyea EP et al. CD6+ Donor marrow T-cell depletion as the sole form of graftversus-host disease prophylaxis in patients undergoing allogeneic bone marrow transplant from unrelated donors. J Clin Oncol 2001; 19: 1152-9.
    • (2001) J Clin Oncol , vol.19 , pp. 1152-1159
    • Soiffer, R.J.1    Weller, E.2    Alyea, E.P.3
  • 73
    • 0027526116 scopus 로고
    • Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program
    • Kernan NA, Bartsch G, Ash RC et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med 1993; 328: 593-602.
    • (1993) N Engl J Med , vol.328 , pp. 593-602
    • Kernan, N.A.1    Bartsch, G.2    Ash, R.C.3
  • 74
    • 0025817169 scopus 로고
    • Bone marrow transplantation from related donors other than HLA-identical siblings: effect of T cell depletion
    • Ash RC, Horowitz MM, Gale RP et al. Bone marrow transplantation from related donors other than HLA-identical siblings: effect of T cell depletion. Bone Marrow Transplant 1991; 7: 443-52.
    • (1991) Bone Marrow Transplant , vol.7 , pp. 443-452
    • Ash, R.C.1    Horowitz, M.M.2    Gale, R.P.3
  • 75
    • 0031111689 scopus 로고    scopus 로고
    • CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors
    • Soiffer RJ, Mauch P, Fairclough D et al. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors. Biol Blood Marrow Transplant 1997; 3: 11-17.
    • (1997) Biol Blood Marrow Transplant , vol.3 , pp. 11-17
    • Soiffer, R.J.1    Mauch, P.2    Fairclough, D.3
  • 76
    • 0030965273 scopus 로고    scopus 로고
    • Use of partially mismatched related donors extends access to allogeneic marrow transplant
    • Henslee-Downey PJ, Abhyankar SH et al. Use of partially mismatched related donors extends access to allogeneic marrow transplant. Blood 1997; 89: 3864-8.
    • (1997) Blood , vol.89 , pp. 3864-3868
    • Henslee-Downey, P.J.1    Abhyankar, S.H.2
  • 77
    • 12144286762 scopus 로고    scopus 로고
    • Bone marrow transplantation from partially HLA-mismatched family donors for acute leukemia: single-center experience of 201 patients
    • Mehta J, Singhal S, Gee AP et al. Bone marrow transplantation from partially HLA-mismatched family donors for acute leukemia: single-center experience of 201 patients. Bone Marrow Transplant 2004; 33: 389-96.
    • (2004) Bone Marrow Transplant , vol.33 , pp. 389-396
    • Mehta, J.1    Singhal, S.2    Gee, A.P.3
  • 78
    • 0032558759 scopus 로고    scopus 로고
    • Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype
    • Aversa F, Tabilio A, Velardi A et al. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. N Engl J Med 1998; 339: 1186-93.
    • (1998) N Engl J Med , vol.339 , pp. 1186-1193
    • Aversa, F.1    Tabilio, A.2    Velardi, A.3
  • 79
    • 33745175166 scopus 로고    scopus 로고
    • Haploidentical stem cell transplantation for children with acute leukaemia
    • Marks DI, Khattry N, Cummins M et al. Haploidentical stem cell transplantation for children with acute leukaemia. Br J Haematol 2006; 134: 196-201.
    • (2006) Br J Haematol , vol.134 , pp. 196-201
    • Marks, D.I.1    Khattry, N.2    Cummins, M.3
  • 80
    • 33947591868 scopus 로고    scopus 로고
    • Partially matched, nonmyeloablative allogeneic transplantation: clinical outcomes and immune reconstitution
    • Rizzieri DA, Koh LP, Long GD et al. Partially matched, nonmyeloablative allogeneic transplantation: clinical outcomes and immune reconstitution. J Clin Oncol 2007; 25: 690-7.
    • (2007) J Clin Oncol , vol.25 , pp. 690-697
    • Rizzieri, D.A.1    Koh, L.P.2    Long, G.D.3
  • 81
    • 17444395247 scopus 로고    scopus 로고
    • Complex interactions: the immunogenetics of human leukocyte antigen and killer cell immunoglobulin-like receptors
    • Norman PJ, Parham P. Complex interactions: the immunogenetics of human leukocyte antigen and killer cell immunoglobulin-like receptors. Semin Hematol 2005; 42: 65-75.
    • (2005) Semin Hematol , vol.42 , pp. 65-75
    • Norman, P.J.1    Parham, P.2
  • 82
    • 17444428649 scopus 로고    scopus 로고
    • Natural killer cell receptors: regulating innate immune responses to hematologic malignancy
    • Hsu K, Dupont B. Natural killer cell receptors: regulating innate immune responses to hematologic malignancy. Semin Hematol 2005; 42: 91-103.
    • (2005) Semin Hematol , vol.42 , pp. 91-103
    • Hsu, K.1    Dupont, B.2
  • 83
    • 0033168770 scopus 로고    scopus 로고
    • Role of natural killer cell alloreactivity in HLAmismatched hematopoietic stem cell transplantation
    • Ruggeri L, Capanni M, Casucci M et al. Role of natural killer cell alloreactivity in HLAmismatched hematopoietic stem cell transplantation. Blood 1999; 94: 333-9.
    • (1999) Blood , vol.94 , pp. 333-339
    • Ruggeri, L.1    Capanni, M.2    Casucci, M.3
  • 84
    • 0037086131 scopus 로고    scopus 로고
    • Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
    • Ruggeri L, Capanni M, Urbani E et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002; 295: 2097-100.
    • (2002) Science , vol.295 , pp. 2097-2100
    • Ruggeri, L.1    Capanni, M.2    Urbani, E.3
  • 85
    • 10744230735 scopus 로고    scopus 로고
    • Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors
    • Giebel S, Locatelli F, Lamparelli T et al. Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors. Blood 2003; 102: 814-19.
    • (2003) Blood , vol.102 , pp. 814-819
    • Giebel, S.1    Locatelli, F.2    Lamparelli, T.3
  • 86
    • 20444394742 scopus 로고    scopus 로고
    • Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes
    • Hsu K, Keever-Taylor CA, Wilton A et al. Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes. Blood 2005; 105: 4878-84.
    • (2005) Blood , vol.105 , pp. 4878-4884
    • Hsu, K.1    Keever-Taylor, C.A.2    Wilton, A.3
  • 87
    • 0037111776 scopus 로고    scopus 로고
    • Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants. Killer immunoglobulin-like receptor
    • Davies SM, Ruggieri L, DeFor T et al. Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants. Killer immunoglobulin-like receptor. Blood 2002; 100: 3825-7.
    • (2002) Blood , vol.100 , pp. 3825-3827
    • Davies, S.M.1    Ruggieri, L.2    DeFor, T.3
  • 88
    • 33746096999 scopus 로고    scopus 로고
    • The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry
    • Farag SS, Bacigalupo A, Eapen M et al. The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry. Biol Blood Marrow Transplant 2006; 12: 876-84.
    • (2006) Biol Blood Marrow Transplant , vol.12 , pp. 876-884
    • Farag, S.S.1    Bacigalupo, A.2    Eapen, M.3
  • 89
    • 34250307061 scopus 로고    scopus 로고
    • Killer-cell immunoglobulin-like receptor ligand compatibility in the outcome of Finnish unrelated donor hematopoietic stem cell transplantation
    • Sivula J, Volin L, Porkka K et al. Killer-cell immunoglobulin-like receptor ligand compatibility in the outcome of Finnish unrelated donor hematopoietic stem cell transplantation. Transplant Immunol 2007; 18: 62-6.
    • (2007) Transplant Immunol , vol.18 , pp. 62-66
    • Sivula, J.1    Volin, L.2    Porkka, K.3
  • 90
    • 34548798651 scopus 로고    scopus 로고
    • Rapid natural killer cell recovery determines outcome after T-cell-depleted HLA-identical stem cell transplantation in patients with myeloid leukemias but not with acute lymphoblastic leukemia
    • Savani BN, Mielke S, Adams S et al. Rapid natural killer cell recovery determines outcome after T-cell-depleted HLA-identical stem cell transplantation in patients with myeloid leukemias but not with acute lymphoblastic leukemia. Leukemia 2007; 21: 2145-52.
    • (2007) Leukemia , vol.21 , pp. 2145-2152
    • Savani, B.N.1    Mielke, S.2    Adams, S.3
  • 91
    • 34848851334 scopus 로고    scopus 로고
    • Reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation
    • Alousi A, de Lima M. Reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation. Clin Adv Hematol Oncol 2007; 7: 560-70.
    • (2007) Clin Adv Hematol Oncol , vol.7 , pp. 560-570
    • Alousi, A.1    de Lima, M.2
  • 92
    • 33750081766 scopus 로고    scopus 로고
    • Stem cell transplantation with reduced-intensity conditioning regimens: a review of ten years experience with new transplant concepts and new therapeutic agents
    • Barrett AJ, Savani BM. Stem cell transplantation with reduced-intensity conditioning regimens: a review of ten years experience with new transplant concepts and new therapeutic agents. Leukemia 2006; 20: 1661-72.
    • (2006) Leukemia , vol.20 , pp. 1661-1672
    • Barrett, A.J.1    Savani, B.M.2
  • 93
    • 0036838640 scopus 로고    scopus 로고
    • Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders
    • Perez-Simon JA, Kottaridis PD, Martino R et al. Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders. Blood 2002; 100: 3121-7.
    • (2002) Blood , vol.100 , pp. 3121-3127
    • Perez-Simon, J.A.1    Kottaridis, P.D.2    Martino, R.3
  • 94
    • 0037097836 scopus 로고    scopus 로고
    • High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution
    • Chakrabarti S, Mackinnon S, Chopra R et al. High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution. Blood 2002; 99: 4357-63.
    • (2002) Blood , vol.99 , pp. 4357-4363
    • Chakrabarti, S.1    Mackinnon, S.2    Chopra, R.3
  • 95
    • 10744221402 scopus 로고    scopus 로고
    • Infectious complications following allogeneic HLA-identical sibling transplantation with antithymocyte globulin-based reduced intensity preparative regimen
    • Mohty M, Jacot W, Faucher C et al. Infectious complications following allogeneic HLA-identical sibling transplantation with antithymocyte globulin-based reduced intensity preparative regimen. Leukemia 2003; 17: 2168-77.
    • (2003) Leukemia , vol.17 , pp. 2168-2177
    • Mohty, M.1    Jacot, W.2    Faucher, C.3
  • 96
    • 10744228219 scopus 로고    scopus 로고
    • Incidence and outcome of adenovirus disease in transplant recipients after reduced-intensity conditioning with alemtuzumab
    • Avivi I, Chakrabarti S, Milligan DW et al. Incidence and outcome of adenovirus disease in transplant recipients after reduced-intensity conditioning with alemtuzumab. Biol Blood Marrow Transplant 2004; 10: 186-94.
    • (2004) Biol Blood Marrow Transplant , vol.10 , pp. 186-194
    • Avivi, I.1    Chakrabarti, S.2    Milligan, D.W.3
  • 97
    • 23244431995 scopus 로고    scopus 로고
    • Reduced-intensity conditioning followed by allografting of CD34-selected stem cells and < or =10(6)/kg T cells may have an adverse effect on transplant-related mortality
    • Hartwig UF, Winkelmann N, Wehler T et al. Reduced-intensity conditioning followed by allografting of CD34-selected stem cells and < or =10(6)/kg T cells may have an adverse effect on transplant-related mortality. Ann Hematol 2005; 84: 331-8.
    • (2005) Ann Hematol , vol.84 , pp. 331-338
    • Hartwig, U.F.1    Winkelmann, N.2    Wehler, T.3
  • 98
    • 27744558612 scopus 로고    scopus 로고
    • Cytomegalovirus (CMV) infections and CMV-specific cellular immune reconstitution following reduced intensity conditioning allogeneic stem cell transplantation with alemtuzumab
    • Lamba R, Carrum G, Myers GD et al. Cytomegalovirus (CMV) infections and CMV-specific cellular immune reconstitution following reduced intensity conditioning allogeneic stem cell transplantation with alemtuzumab. Bone Marrow Transplant 2005; 36: 797-802.
    • (2005) Bone Marrow Transplant , vol.36 , pp. 797-802
    • Lamba, R.1    Carrum, G.2    Myers, G.D.3
  • 99
    • 0842307308 scopus 로고    scopus 로고
    • Doseescalated donor lymphocyte infusions following reduced intensity transplantation: toxicity, chimerism, and disease responses
    • Peggs KS, Thomson K, Hart DP et al. Doseescalated donor lymphocyte infusions following reduced intensity transplantation: toxicity, chimerism, and disease responses. Blood 2004; 103: 1548-56.
    • (2004) Blood , vol.103 , pp. 1548-1556
    • Peggs, K.S.1    Thomson, K.2    Hart, D.P.3
  • 100
    • 33846003456 scopus 로고    scopus 로고
    • Prophylactic transfer of CD8-depleted donor lymphocytes after T-cell-depleted reduced-intensity transplantation
    • Meyer RG, Britten CM, Wehler D et al. Prophylactic transfer of CD8-depleted donor lymphocytes after T-cell-depleted reduced-intensity transplantation. Blood 2007; 109: 374-82.
    • (2007) Blood , vol.109 , pp. 374-382
    • Meyer, R.G.1    Britten, C.M.2    Wehler, D.3
  • 101
    • 33845259299 scopus 로고    scopus 로고
    • T-cell depleted peripheral blood stem cell allotransplantation with T-cell add-back for patients with hematological malignancies: effect of chronic GVHD on outcome
    • Montero A, Savani BN, Shenoy A et al. T-cell depleted peripheral blood stem cell allotransplantation with T-cell add-back for patients with hematological malignancies: effect of chronic GVHD on outcome. Biol Blood Marrow Transplant 2006; 12: 1318-25.
    • (2006) Biol Blood Marrow Transplant , vol.12 , pp. 1318-1325
    • Montero, A.1    Savani, B.N.2    Shenoy, A.3
  • 102
    • 9144246514 scopus 로고    scopus 로고
    • T-cell reconstitution after unmanipulated, CD8-depleted or CD34-selected nonmyeloablative peripheral blood stem-cell transplantation
    • Baron F, Schaaf-Lafontaine N, Humblet-Baron S et al. T-cell reconstitution after unmanipulated, CD8-depleted or CD34-selected nonmyeloablative peripheral blood stem-cell transplantation. Transplantation 2003; 76: 1705-13.
    • (2003) Transplantation , vol.76 , pp. 1705-1713
    • Baron, F.1    Schaaf-Lafontaine, N.2    Humblet-Baron, S.3
  • 103
    • 33745449021 scopus 로고    scopus 로고
    • Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation
    • Bacigalupo A, Lamparelli T, Barisione G et al. Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation. Biol Blood Marrow Transplant 2006; 12: 560-5.
    • (2006) Biol Blood Marrow Transplant , vol.12 , pp. 560-565
    • Bacigalupo, A.1    Lamparelli, T.2    Barisione, G.3
  • 104
    • 33745470309 scopus 로고    scopus 로고
    • Reduced incidence of acute and chronic graft-versus-host disease with the addition of thymoglobulin to a targeted busulfan/cyclophosphamide regimen
    • Deeg HJ, Storer BE, Boeckh M et al. Reduced incidence of acute and chronic graft-versus-host disease with the addition of thymoglobulin to a targeted busulfan/cyclophosphamide regimen. Biol Blood Marrow Transplant 2006; 12: 573-84.
    • (2006) Biol Blood Marrow Transplant , vol.12 , pp. 573-584
    • Deeg, H.J.1    Storer, B.E.2    Boeckh, M.3
  • 105
    • 27644515599 scopus 로고    scopus 로고
    • Influence of T-cell depletion on chronic graft-versushost disease: results of a multicenter randomized trial in unrelated marrow donor transplantation
    • Pavletic SZ, Carter SL, Kernan NA et al. Influence of T-cell depletion on chronic graft-versushost disease: results of a multicenter randomized trial in unrelated marrow donor transplantation. Blood 2005; 106: 3308-13.
    • (2005) Blood , vol.106 , pp. 3308-3313
    • Pavletic, S.Z.1    Carter, S.L.2    Kernan, N.A.3
  • 106
    • 22144466581 scopus 로고    scopus 로고
    • A comparison of postengraftment infectious morbidity and mortality after allogeneic partially T celldepleted peripheral blood progenitor cell transplantation versus T cell-depleted bone marrow transplantation
    • Broers AE, van der Holt B, Haze S et al. A comparison of postengraftment infectious morbidity and mortality after allogeneic partially T celldepleted peripheral blood progenitor cell transplantation versus T cell-depleted bone marrow transplantation. Exp Hematol 2205; 33: 912-19.
    • (2205) Exp Hematol , vol.33 , pp. 912-919
    • Broers, A.E.1    van der Holt, B.2    Haze, S.3
  • 107
    • 0035039140 scopus 로고    scopus 로고
    • Prognostic factors for early severe pulmonary complications after hematopoietic stem cell transplantation
    • Ho VT, Weller E, Lee SJ et al. Prognostic factors for early severe pulmonary complications after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2001; 7: 223-9.
    • (2001) Biol Blood Marrow Transplant , vol.7 , pp. 223-229
    • Ho, V.T.1    Weller, E.2    Lee, S.J.3
  • 108
    • 0026347036 scopus 로고
    • Hepatic dysfunction following T-cell-depleted allogeneic bone marrow transplantation
    • Soiffer RJ, Dear K, Rabinowe SN et al. Hepatic dysfunction following T-cell-depleted allogeneic bone marrow transplantation. Transplantation 1991; 52: 1014-19.
    • (1991) Transplantation , vol.52 , pp. 1014-1019
    • Soiffer, R.J.1    Dear, K.2    Rabinowe, S.N.3
  • 109
    • 10744231461 scopus 로고    scopus 로고
    • Positive selection for CD34+ reduces the incidence and severity of veno-occlusive disease of the liver after HLA-identical sibling allogeneic peripheral blood stem cell transplantation
    • Moscardo F, Urbano-Ispizua A, Sanz GF, Brunet S et al. Positive selection for CD34+ reduces the incidence and severity of veno-occlusive disease of the liver after HLA-identical sibling allogeneic peripheral blood stem cell transplantation. Exp Hematol 2003; 31: 545-50.
    • (2003) Exp Hematol , vol.31 , pp. 545-550
    • Moscardo, F.1    Urbano-Ispizua, A.2    Sanz, G.F.3    Brunet, S.4
  • 110
    • 33749441471 scopus 로고    scopus 로고
    • Pulmonary complications after T-cell-depleted allogeneic stem cell transplantation: low incidence and strong association with acute graft-versus-host disease
    • Huisman C, van der Straaten HM, Canninga van Dijk MR et al. Pulmonary complications after T-cell-depleted allogeneic stem cell transplantation: low incidence and strong association with acute graft-versus-host disease. Bone Marrow Transplant 2006; 38: 561-6.
    • (2006) Bone Marrow Transplant , vol.38 , pp. 561-566
    • Huisman, C.1    van der Straaten, H.M.2    Canninga van Dijk, M.R.3
  • 111
    • 0037108291 scopus 로고    scopus 로고
    • Comparison of T-cell-depleted and non-T-cell-depleted unrelated donor transplantation for hematologic diseases: clinical outcomes, quality of life, and costs
    • Lee SJ, Zahrieh D, Alyea EP et al. Comparison of T-cell-depleted and non-T-cell-depleted unrelated donor transplantation for hematologic diseases: clinical outcomes, quality of life, and costs. Blood 2002: 100: 2697-72.
    • (2002) Blood , vol.100 , pp. 2697-2672
    • Lee, S.J.1    Zahrieh, D.2    Alyea, E.P.3
  • 112
    • 0028208561 scopus 로고
    • Control of graft-versushost disease and graft rejection by T cell depletion of donor and recipient with Campath-1 antibodies. Results of matched sibling transplants for malignant diseases
    • Hale G, Waldmann H. Control of graft-versushost disease and graft rejection by T cell depletion of donor and recipient with Campath-1 antibodies. Results of matched sibling transplants for malignant diseases. Bone Marrow Transplant 1994; 13: 597-611.
    • (1994) Bone Marrow Transplant , vol.13 , pp. 597-611
    • Hale, G.1    Waldmann, H.2
  • 113
    • 0024427624 scopus 로고
    • Graft failure after T-cell-depleted leukocyte antigen identical marrow transplants for leukemia. I. Analysis of risk factors and results of secondary transplants
    • Kernan NA, Bordignon C, Heller G et al. Graft failure after T-cell-depleted leukocyte antigen identical marrow transplants for leukemia. I. Analysis of risk factors and results of secondary transplants. Blood 1989; 74: 2227-36.
    • (1989) Blood , vol.74 , pp. 2227-2236
    • Kernan, N.A.1    Bordignon, C.2    Heller, G.3
  • 114
    • 0027729389 scopus 로고
    • Graft failure after T cell depleted HLA identical allogeneic bone marrow transplantation: risk factors in leukemic patients
    • Delain M, Cahn JY, Racadot E et al. Graft failure after T cell depleted HLA identical allogeneic bone marrow transplantation: risk factors in leukemic patients. Leuk Lymphoma 1993; 11: 359-68.
    • (1993) Leuk Lymphoma , vol.11 , pp. 359-368
    • Delain, M.1    Cahn, J.Y.2    Racadot, E.3
  • 115
    • 0023719305 scopus 로고
    • Graft failure in patients receiving T cell-depleted HLAidentical allogeneic marrow transplants
    • Martin PJ, Hansen JA, Torok-Storb B et al. Graft failure in patients receiving T cell-depleted HLAidentical allogeneic marrow transplants. Bone Marrow Transplant 1988; 3: 445-56.
    • (1988) Bone Marrow Transplant , vol.3 , pp. 445-456
    • Martin, P.J.1    Hansen, J.A.2    Torok-Storb, B.3
  • 116
    • 0022553698 scopus 로고
    • Transplantation of HLA-haploidentical T cell-depleted marrow for leukemia: autologous marrow recovery with specific immune sensitization to donor antigens
    • Sondel PM, Hank JA, Trigg ME et al. Transplantation of HLA-haploidentical T cell-depleted marrow for leukemia: autologous marrow recovery with specific immune sensitization to donor antigens. Exp Hematol 1986; 14: 278-86.
    • (1986) Exp Hematol , vol.14 , pp. 278-286
    • Sondel, P.M.1    Hank, J.A.2    Trigg, M.E.3
  • 117
    • 0023197452 scopus 로고
    • Evidence for the involvement of host derived OKT8-positive T cells in the rejection of T-depleted, HLA-identical bone marrow grafts
    • Bunjes D, Heit W, Arnold R et al. Evidence for the involvement of host derived OKT8-positive T cells in the rejection of T-depleted, HLA-identical bone marrow grafts. Transplantation 1987; 43: 501-5.
    • (1987) Transplantation , vol.43 , pp. 501-505
    • Bunjes, D.1    Heit, W.2    Arnold, R.3
  • 118
    • 0027170545 scopus 로고
    • Graft rejection by a population of primed CDw52-host T cells after in vivo/ex vivo T-depleted bone marrow transplantation
    • Bunjes D, Theobald M, Wiesneth M et al. Graft rejection by a population of primed CDw52-host T cells after in vivo/ex vivo T-depleted bone marrow transplantation. Bone Marrow Transplant 1993; 12: 209-15.
    • (1993) Bone Marrow Transplant , vol.12 , pp. 209-215
    • Bunjes, D.1    Theobald, M.2    Wiesneth, M.3
  • 119
    • 0023189896 scopus 로고
    • Graft rejection in recipients of T cell depleted HLA-nonidentical marrow transplants for leukemia
    • Kernan NA, Flomenberg N, Dupont B, O'Reilly RJ. Graft rejection in recipients of T cell depleted HLA-nonidentical marrow transplants for leukemia. Transplantation 1987; 43: 842-7.
    • (1987) Transplantation , vol.43 , pp. 842-847
    • Kernan, N.A.1    Flomenberg, N.2    Dupont, B.3    O'Reilly, R.J.4
  • 120
    • 0010683130 scopus 로고
    • Regulation of cytotoxic T lymphocyte-mediated graft rejection following bone marrow transplantation
    • Bierer BE, Emerson SG, Antin J et al. Regulation of cytotoxic T lymphocyte-mediated graft rejection following bone marrow transplantation. Transplantation 1990; 49: 714-20.
    • (1990) Transplantation , vol.49 , pp. 714-720
    • Bierer, B.E.1    Emerson, S.G.2    Antin, J.3
  • 121
    • 0024429365 scopus 로고
    • Graft failure after T-cell-depleted leukocyte antigen identical marrow transplants for leukemia. II. In vitro analysis of host effector mechanisms
    • Bordignon C, Keever CA, Small TN et al. Graft failure after T-cell-depleted leukocyte antigen identical marrow transplants for leukemia. II. In vitro analysis of host effector mechanisms. Blood 1989; 74: 2237-43.
    • (1989) Blood , vol.74 , pp. 2237-2243
    • Bordignon, C.1    Keever, C.A.2    Small, T.N.3
  • 122
    • 0024393550 scopus 로고
    • Mechanism of graft failure in HLA-matched and HLA-mismatched bone marrow transplant recipients
    • Bosserman L, Murray C, Takvorian T et al. Mechanism of graft failure in HLA-matched and HLA-mismatched bone marrow transplant recipients. Bone Marrow Transplant 1989; 4: 239-45.
    • (1989) Bone Marrow Transplant , vol.4 , pp. 239-245
    • Bosserman, L.1    Murray, C.2    Takvorian, T.3
  • 123
    • 0025096695 scopus 로고
    • Rejection of bone marrow graft by recipient derived cytotoxic T lymphocytes against minor histocompatibility antigens
    • Voogt PJ, Fibbe WE, Marjit WA et al. Rejection of bone marrow graft by recipient derived cytotoxic T lymphocytes against minor histocompatibility antigens. Lancet 1990; 335: 135-44.
    • (1990) Lancet , vol.335 , pp. 135-144
    • Voogt, P.J.1    Fibbe, W.E.2    Marjit, W.A.3
  • 124
    • 0025634104 scopus 로고
    • Bone marrow-allograft rejection by T lymphocytes recognizing a single amino acid difference on HLA-B44
    • Fleischauer K, Kernan NA, O'Reilly RJ, Dupont B, Tang SY. Bone marrow-allograft rejection by T lymphocytes recognizing a single amino acid difference on HLA-B44. N Engl J Med 1990; 323: 1818-22.
    • (1990) N Engl J Med , vol.323 , pp. 1818-1822
    • Fleischauer, K.1    Kernan, N.A.2    O'Reilly, R.J.3    Dupont, B.4    Tang, S.Y.5
  • 125
    • 0027249574 scopus 로고
    • Characterization of cells emerging at the time of graft failure after bone marrow transplantation from an unrelated marrow donor
    • Donohue J, Homge M, Kernan NA. Characterization of cells emerging at the time of graft failure after bone marrow transplantation from an unrelated marrow donor. Blood 1993; 82: 1023-9.
    • (1993) Blood , vol.82 , pp. 1023-1029
    • Donohue, J.1    Homge, M.2    Kernan, N.A.3
  • 126
    • 0033214650 scopus 로고    scopus 로고
    • A phase I-II clinical trial to evaluate removal of CD4 cells and partial depletion of CD8 cells from donor marrow for HLA-mismatched unrelated recipients
    • Martin PJ, Rowley SD, Anasetti C et al. A phase I-II clinical trial to evaluate removal of CD4 cells and partial depletion of CD8 cells from donor marrow for HLA-mismatched unrelated recipients. Blood 1999; 94: 2192-9.
    • (1999) Blood , vol.94 , pp. 2192-2199
    • Martin, P.J.1    Rowley, S.D.2    Anasetti, C.3
  • 127
    • 0023951735 scopus 로고
    • Failure in generating hemopoietic stem cells is the primary cause of death from cytomegalovirus disease in the immunocompromised host
    • Mutter W, Reddehase MJ, Busch FW et al. Failure in generating hemopoietic stem cells is the primary cause of death from cytomegalovirus disease in the immunocompromised host. J Exp Med 1988; 167: 1645-58.
    • (1988) J Exp Med , vol.167 , pp. 1645-1658
    • Mutter, W.1    Reddehase, M.J.2    Busch, F.W.3
  • 128
    • 0031924470 scopus 로고    scopus 로고
    • Cytomegalovirus inhibits the engraftment of donor bone marrow cells by downregulation of hemopoietin gene expression in recipient stroma
    • Steffens HP, Podlech J, Kurz S et al. Cytomegalovirus inhibits the engraftment of donor bone marrow cells by downregulation of hemopoietin gene expression in recipient stroma. J Virol 1998; 72: 5006-15.
    • (1998) J Virol , vol.72 , pp. 5006-5015
    • Steffens, H.P.1    Podlech, J.2    Kurz, S.3
  • 129
    • 0032992228 scopus 로고    scopus 로고
    • HHV-6-related secondary graft failure following allogeneic bone marrow transplantation
    • Johnston RE, Geretti AM, Prentice HG et al. HHV-6-related secondary graft failure following allogeneic bone marrow transplantation. Br J Haematol 1999; 105: 1041-3.
    • (1999) Br J Haematol , vol.105 , pp. 1041-1043
    • Johnston, R.E.1    Geretti, A.M.2    Prentice, H.G.3
  • 130
    • 0029009916 scopus 로고
    • Late graft failure due to dual bone marrow infection with variants A and B of human herpesvirus-6
    • Rosenfeld CS, Rybka WB, Weinbaum et al. Late graft failure due to dual bone marrow infection with variants A and B of human herpesvirus-6. Exp Hematol 1995; 23: 626-9.
    • (1995) Exp Hematol , vol.23 , pp. 626-629
    • Rosenfeld, C.S.1    Rybka, W.B.2    Weinbaum3
  • 131
    • 0023322694 scopus 로고
    • Graft rejection after T cell-depleted marrow transplantation: role of fractionated irradiation
    • Guyotat D, Dutou L, Erhsam A et al. Graft rejection after T cell-depleted marrow transplantation: role of fractionated irradiation. Br J Haematol 1987; 65: 499-507.
    • (1987) Br J Haematol , vol.65 , pp. 499-507
    • Guyotat, D.1    Dutou, L.2    Erhsam, A.3
  • 132
    • 0023940608 scopus 로고
    • Prevention of graft-versus-host disease by ex vivo T cell depletion: reduction in graft failure with augmented total body irradiation
    • Burnett AK, Hann IM, Robertson AG et al. Prevention of graft-versus-host disease by ex vivo T cell depletion: reduction in graft failure with augmented total body irradiation. Leukemia 1988; 2: 300-3.
    • (1988) Leukemia , vol.2 , pp. 300-303
    • Burnett, A.K.1    Hann, I.M.2    Robertson, A.G.3
  • 133
    • 0022350217 scopus 로고
    • Transplantation of HLA-haploidentical T-cell-depleted marrow for leukemia: addition of cytosine arabinoside to the pretransplant conditioning prevents rejection
    • Bozdech MJ, Sondel PM, Trigg ME et al. Transplantation of HLA-haploidentical T-cell-depleted marrow for leukemia: addition of cytosine arabinoside to the pretransplant conditioning prevents rejection. Exp Hematol 1985; 13: 1201-10.
    • (1985) Exp Hematol , vol.13 , pp. 1201-1210
    • Bozdech, M.J.1    Sondel, P.M.2    Trigg, M.E.3
  • 134
    • 0034782756 scopus 로고    scopus 로고
    • Transplant dose of CD34(+) and CD3(+) cells predicts outcome in patients with haematological malignancies undergoing T cell-depleted peripheral blood stem cell transplants with delayed donor lymphocyte add-back
    • Nakamura R, Bahceci E, Read EJ et al. Transplant dose of CD34(+) and CD3(+) cells predicts outcome in patients with haematological malignancies undergoing T cell-depleted peripheral blood stem cell transplants with delayed donor lymphocyte add-back. Br J Haematol 2001; 115: 95-104.
    • (2001) Br J Haematol , vol.115 , pp. 95-104
    • Nakamura, R.1    Bahceci, E.2    Read, E.J.3
  • 135
    • 39649110913 scopus 로고    scopus 로고
    • T cell depleted stem-cell transplantation for adults with hematologic malignancies: sustained engraftment of HLA-matched related donor grafts without the use of antithymocyte globulin
    • Jakubowski AA, Small TN, Young JW et al. T cell depleted stem-cell transplantation for adults with hematologic malignancies: sustained engraftment of HLA-matched related donor grafts without the use of antithymocyte globulin. Blood 2007; 110: 4552-9.
    • (2007) Blood , vol.110 , pp. 4552-4559
    • Jakubowski, A.A.1    Small, T.N.2    Young, J.W.3
  • 136
    • 0025021373 scopus 로고
    • Natural history of mixed chimerism after bone marrow transplantation with CD6-depleted allogeneic marrow: a stable equilibrium
    • Roy DC, Tantravahi R, Murray C et al. Natural history of mixed chimerism after bone marrow transplantation with CD6-depleted allogeneic marrow: a stable equilibrium. Blood 1990; 75: 296-304.
    • (1990) Blood , vol.75 , pp. 296-304
    • Roy, D.C.1    Tantravahi, R.2    Murray, C.3
  • 137
    • 0033642531 scopus 로고    scopus 로고
    • Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLAmatched donor bone marrow transplantation for refractory hematologic malignancies
    • Spitzer TR, McAfee S, Sackstein R et al. Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLAmatched donor bone marrow transplantation for refractory hematologic malignancies. Biol Blood Marrow Transplant 2000; 6: 309-20.
    • (2000) Biol Blood Marrow Transplant , vol.6 , pp. 309-320
    • Spitzer, T.R.1    McAfee, S.2    Sackstein, R.3
  • 138
    • 0032852141 scopus 로고    scopus 로고
    • Combined histocompatibility leukocyte antigenmatched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: the induction of allograft tolerance through mixed lymphohematopoietic chimerism
    • Spitzer TR, Delmonico F, Tolkoff-Rubin N et al. Combined histocompatibility leukocyte antigenmatched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: the induction of allograft tolerance through mixed lymphohematopoietic chimerism. Transplantation 1999; 68: 480-4.
    • (1999) Transplantation , vol.68 , pp. 480-484
    • Spitzer, T.R.1    Delmonico, F.2    Tolkoff-Rubin, N.3
  • 139
    • 41549092812 scopus 로고    scopus 로고
    • Chimerism does not predict for outcome after alemtuzumabbased conditioning: lineage-specific analysis of chimerism of specific diseases may be more informative
    • Lim ZY, Pearce L, Ingram W et al. Chimerism does not predict for outcome after alemtuzumabbased conditioning: lineage-specific analysis of chimerism of specific diseases may be more informative. Bone Marrow Transplant 2008; 41: 587-8.
    • (2008) Bone Marrow Transplant , vol.41 , pp. 587-588
    • Lim, Z.Y.1    Pearce, L.2    Ingram, W.3
  • 140
    • 0024600728 scopus 로고
    • Immune reconstitution following bone marrow transplantation: comparison of recipients of T-cell depleted marrow with recipients of conventional marrow grafts
    • Keever CA, Small TN, Flomenberg N et al. Immune reconstitution following bone marrow transplantation: comparison of recipients of T-cell depleted marrow with recipients of conventional marrow grafts. Blood 1989; 73: 1340-50.
    • (1989) Blood , vol.73 , pp. 1340-1350
    • Keever, C.A.1    Small, T.N.2    Flomenberg, N.3
  • 141
    • 0021810186 scopus 로고
    • Phenotype of recovering lymphoid cell populations after marrow transplantation
    • Ault KA, Antin JH, Ginsburg D et al. Phenotype of recovering lymphoid cell populations after marrow transplantation. J Exp Med 1985; 161: 1483-502.
    • (1985) J Exp Med , vol.161 , pp. 1483-1502
    • Ault, K.A.1    Antin, J.H.2    Ginsburg, D.3
  • 142
    • 0023576099 scopus 로고
    • Interleukin-2 production and response to interleukin-2 by peripheral blood mononuclear cells from patients after bone marrow transplantation. II. Patients receiving soybean lectin-separated and T celldepleted bone marrow
    • Welte K, Keever CA, Levick J et al. Interleukin-2 production and response to interleukin-2 by peripheral blood mononuclear cells from patients after bone marrow transplantation. II. Patients receiving soybean lectin-separated and T celldepleted bone marrow. Blood 1987; 70: 1595-603.
    • (1987) Blood , vol.70 , pp. 1595-1603
    • Welte, K.1    Keever, C.A.2    Levick, J.3
  • 143
    • 0025346261 scopus 로고
    • Reconstitution of T-cell function after CD6-depleted allogeneic bone marrow transplantation
    • Soiffer RJ, Bosserman L, Murray C et al. Reconstitution of T-cell function after CD6-depleted allogeneic bone marrow transplantation. Blood 1990; 75: 2076-84.
    • (1990) Blood , vol.75 , pp. 2076-2084
    • Soiffer, R.J.1    Bosserman, L.2    Murray, C.3
  • 144
    • 0029922179 scopus 로고    scopus 로고
    • Analysis of T-cell repopulation after allogeneic bone marrow transplantation: significant differences between recipients of T-cell depleted and unmanipulated grafts
    • Roux E, Helg C, Dumont-Girard F et al. Analysis of T-cell repopulation after allogeneic bone marrow transplantation: significant differences between recipients of T-cell depleted and unmanipulated grafts. Blood 1996; 87: 3984-92.
    • (1996) Blood , vol.87 , pp. 3984-3992
    • Roux, E.1    Helg, C.2    Dumont-Girard, F.3
  • 145
    • 0033966371 scopus 로고    scopus 로고
    • Reconstitution of T-cell receptor repertoire diversity following T-cell depleted allogeneic bone marrow transplantation is related to hematopoietic chimerism
    • Wu CJ, Chillemi A, Alyea EP et al. Reconstitution of T-cell receptor repertoire diversity following T-cell depleted allogeneic bone marrow transplantation is related to hematopoietic chimerism. Blood 2000; 95: 352-9.
    • (2000) Blood , vol.95 , pp. 352-359
    • Wu, C.J.1    Chillemi, A.2    Alyea, E.P.3
  • 146
    • 0034665895 scopus 로고    scopus 로고
    • Recovery of immune reactivity after T-celldepleted bone marrow transplantation depends on thymic activity
    • Roux E, Dumont-Girard F, Starobinski M et al. Recovery of immune reactivity after T-celldepleted bone marrow transplantation depends on thymic activity. Blood 2000; 96: 2299-303.
    • (2000) Blood , vol.96 , pp. 2299-2303
    • Roux, E.1    Dumont-Girard, F.2    Starobinski, M.3
  • 147
    • 0035883102 scopus 로고    scopus 로고
    • Quantitation of T-cell neogenesis in vivo after allogeneic bone marrow transplantation in adults
    • Hochberg EP, Chillemi A, Wu CJ et al. Quantitation of T-cell neogenesis in vivo after allogeneic bone marrow transplantation in adults. Blood 2001; 98: 1116-21.
    • (2001) Blood , vol.98 , pp. 1116-1121
    • Hochberg, E.P.1    Chillemi, A.2    Wu, C.J.3
  • 148
    • 0344305505 scopus 로고    scopus 로고
    • Donor CMV serologic status and outcome of CMVseropositive recipients after unrelated donor stem cell transplantation: an EBMT megafile analysis
    • Ljungman P, Brand R, Einsele H et al. Donor CMV serologic status and outcome of CMVseropositive recipients after unrelated donor stem cell transplantation: an EBMT megafile analysis. Blood 2003; 102: 4255-60.
    • (2003) Blood , vol.102 , pp. 4255-4260
    • Ljungman, P.1    Brand, R.2    Einsele, H.3
  • 149
    • 0037099415 scopus 로고    scopus 로고
    • Risk factors for cytomegalovirus reactivation after CD6+ Tcell-depleted allogeneic bone marrow transplantation
    • Lin TS, Zahrieh D, Weller E et al. Risk factors for cytomegalovirus reactivation after CD6+ Tcell-depleted allogeneic bone marrow transplantation. Transplantation 2002; 74: 49-54.
    • (2002) Transplantation , vol.74 , pp. 49-54
    • Lin, T.S.1    Zahrieh, D.2    Weller, E.3
  • 150
    • 36048953433 scopus 로고    scopus 로고
    • Higher risk of cytomegalovirus and aspergillus infections in recipients of T cell-depleted unrelated bone marrow: analysis of infectious complications in patients treated with T cell depletion versus immunosuppressive therapy to prevent graftversus-host disease
    • van Burik JA, Carter SL, Freifeld AJ et al. Higher risk of cytomegalovirus and aspergillus infections in recipients of T cell-depleted unrelated bone marrow: analysis of infectious complications in patients treated with T cell depletion versus immunosuppressive therapy to prevent graftversus-host disease. Biol Blood Marrow Transplant 2007; 12: 1487-98.
    • (2007) Biol Blood Marrow Transplant , vol.12 , pp. 1487-1498
    • van Burik, J.A.1    Carter, S.L.2    Freifeld, A.J.3
  • 151
    • 0021194133 scopus 로고
    • Fatal Epstein-Barr virus associated proliferation of donor B-cells after treatment of acute graftversus-host disease with a murine anti-T-cell antibody
    • Martin P, Schulman H, Schubach W et al. Fatal Epstein-Barr virus associated proliferation of donor B-cells after treatment of acute graftversus-host disease with a murine anti-T-cell antibody. Ann Intern Med 1984; 101: 310.
    • (1984) Ann Intern Med , vol.101 , pp. 310
    • Martin, P.1    Schulman, H.2    Schubach, W.3
  • 152
    • 33750621679 scopus 로고    scopus 로고
    • Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation
    • Brunstein CG, Weisdorf DJ, DeFor T et al. Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation. Blood 2006; 108: 2874-80.
    • (2006) Blood , vol.108 , pp. 2874-2880
    • Brunstein, C.G.1    Weisdorf, D.J.2    DeFor, T.3
  • 153
    • 0028288519 scopus 로고
    • Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation
    • Papadopoulos EP, Ladanyi M, Emanuel D et al. Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N Engl J Med 1994; 330: 1185-91.
    • (1994) N Engl J Med , vol.330 , pp. 1185-1191
    • Papadopoulos, E.P.1    Ladanyi, M.2    Emanuel, D.3
  • 154
    • 0034651548 scopus 로고    scopus 로고
    • CD20 monoclonal antibody (rituximab) for therapy of Epstein-Barr virus lymphoma after hemopoietic stem-cell transplantation
    • Kuehnle I, Huls MH, Liu Z et al. CD20 monoclonal antibody (rituximab) for therapy of Epstein-Barr virus lymphoma after hemopoietic stem-cell transplantation. Blood 2000; 95: 1502-5.
    • (2000) Blood , vol.95 , pp. 1502-1505
    • Kuehnle, I.1    Huls, M.H.2    Liu, Z.3
  • 155
    • 0035283115 scopus 로고    scopus 로고
    • Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients
    • Stevens SJ, Verschuuren EA, Pronk I et al. Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients. Blood 2001; 97: 1165-71.
    • (2001) Blood , vol.97 , pp. 1165-1171
    • Stevens, S.J.1    Verschuuren, E.A.2    Pronk, I.3
  • 157
    • 35649022660 scopus 로고    scopus 로고
    • Interleukin-7 induced facilitation of immunological reconstitution of sublethally irradiated mice following treatment with alloreactive spleen cells in a murine model of B-cell leukemia/lymphoma (BCL1)
    • Abdul-Hai A, Weiss L, Ben-Yehuda A et al. Interleukin-7 induced facilitation of immunological reconstitution of sublethally irradiated mice following treatment with alloreactive spleen cells in a murine model of B-cell leukemia/lymphoma (BCL1). Bone Marrow Transplant 2007; 40: 881-9.
    • (2007) Bone Marrow Transplant , vol.40 , pp. 881-889
    • Abdul-Hai, A.1    Weiss, L.2    Ben-Yehuda, A.3
  • 158
    • 34447277881 scopus 로고    scopus 로고
    • Enhanced immune reconstitution by sex steroid ablation following allogeneic hemopoietic stem cell transplantation
    • Goldberg GL, Alpdogan O, Muriglan SJ et al. Enhanced immune reconstitution by sex steroid ablation following allogeneic hemopoietic stem cell transplantation. J Immunol 2007; 178: 7473-84.
    • (2007) J Immunol , vol.178 , pp. 7473-7484
    • Goldberg, G.L.1    Alpdogan, O.2    Muriglan, S.J.3
  • 159
    • 0033519661 scopus 로고    scopus 로고
    • Transplantation of anergic histoincompatible bone marrow allografts [see comments]
    • Guinan EC, Boussiotis VA, Neuberg D et al. Transplantation of anergic histoincompatible bone marrow allografts [see comments]. N Engl J Med 1999; 340: 1704-14.
    • (1999) N Engl J Med , vol.340 , pp. 1704-1714
    • Guinan, E.C.1    Boussiotis, V.A.2    Neuberg, D.3
  • 160
    • 43249122409 scopus 로고    scopus 로고
    • A clinical scale selective allodepletion approach for the treatment of HLA-mismatched and matched donor-recipient pairs using expanded T lymphocytes as antigen-presenting cells and a TH9402-based photodepletion technique
    • Mielke S, Nunes R, Rezvani K et al. A clinical scale selective allodepletion approach for the treatment of HLA-mismatched and matched donor-recipient pairs using expanded T lymphocytes as antigen-presenting cells and a TH9402-based photodepletion technique. Blood 2008; 111: 4392-402.
    • (2008) Blood , vol.111 , pp. 4392-4402
    • Mielke, S.1    Nunes, R.2    Rezvani, K.3
  • 161
    • 33748692890 scopus 로고    scopus 로고
    • Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplantation
    • Amrolia PJ, Muccioli-Casadei G, Huls H et al. Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplantation. Blood 2006; 108: 1797-808.
    • (2006) Blood , vol.108 , pp. 1797-1808
    • Amrolia, P.J.1    Muccioli-Casadei, G.2    Huls, H.3
  • 162
    • 33749514632 scopus 로고    scopus 로고
    • Monoculturederived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals
    • Leen AM, Myers GD, Sili U et al. Monoculturederived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals. Nat Med 2006; 12: 1160-6.
    • (2006) Nat Med , vol.12 , pp. 1160-1166
    • Leen, A.M.1    Myers, G.D.2    Sili, U.3
  • 163
    • 0024262709 scopus 로고
    • HLAidentical marrow transplantation during accelerated-phase chronic myelogenous leukemia: analysis of survival and remission duration
    • Martin P, Clift RA, Fisher LD et al. HLAidentical marrow transplantation during accelerated-phase chronic myelogenous leukemia: analysis of survival and remission duration. Blood 1988; 72: 1978-84.
    • (1988) Blood , vol.72 , pp. 1978-1984
    • Martin, P.1    Clift, R.A.2    Fisher, L.D.3
  • 164
    • 0026773515 scopus 로고
    • HLAidentical sibling donor bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: influence of GVHD prophylaxis on outcome
    • Marks DI, Hughes TP, Szydlo R et al. HLAidentical sibling donor bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: influence of GVHD prophylaxis on outcome. Br J Haematol 1992; 81: 383-90.
    • (1992) Br J Haematol , vol.81 , pp. 383-390
    • Marks, D.I.1    Hughes, T.P.2    Szydlo, R.3
  • 165
    • 0026718041 scopus 로고
    • Bone marrow transplantation of chronic myelogenous leukemia in chronic phase: evaluation of risks and benefits
    • Wagner JE, Zahurak M, Piantadosi S et al. Bone marrow transplantation of chronic myelogenous leukemia in chronic phase: evaluation of risks and benefits. J Clin Oncol 1992; 10: 779-89.
    • (1992) J Clin Oncol , vol.10 , pp. 779-789
    • Wagner, J.E.1    Zahurak, M.2    Piantadosi, S.3
  • 166
    • 0027519484 scopus 로고
    • Bone marrow transplantation for chronic myeloid leukemia: long-term results
    • Gratwohl A, Hermans J, Niderwieser D et al. Bone marrow transplantation for chronic myeloid leukemia: long-term results. Bone Marrow Transplant 1993; 12: 509-16.
    • (1993) Bone Marrow Transplant , vol.12 , pp. 509-516
    • Gratwohl, A.1    Hermans, J.2    Niderwieser, D.3
  • 167
    • 0027514621 scopus 로고
    • Unrelated donor marrow transplantation therapy for chronic myelogenous leukemia: initial experience of the National Marrow Donor Program
    • McGlave P, Bartsch G, Anasetti C et al. Unrelated donor marrow transplantation therapy for chronic myelogenous leukemia: initial experience of the National Marrow Donor Program. Blood 1993; 81: 543-50.
    • (1993) Blood , vol.81 , pp. 543-550
    • McGlave, P.1    Bartsch, G.2    Anasetti, C.3
  • 168
    • 0028856613 scopus 로고
    • Use of unrelated marrow grafts compensates for reduced graft-versus-leukemia reactivity after T-celldepleted allogeneic marrow transplantation for chronic myelogenous leukemia
    • Hessner MJ, Endean DJ, Casper JT et al. Use of unrelated marrow grafts compensates for reduced graft-versus-leukemia reactivity after T-celldepleted allogeneic marrow transplantation for chronic myelogenous leukemia. Blood 1995; 86: 3987-96.
    • (1995) Blood , vol.86 , pp. 3987-3996
    • Hessner, M.J.1    Endean, D.J.2    Casper, J.T.3
  • 169
    • 0030857652 scopus 로고    scopus 로고
    • European results of matched unrelated donor bone marrow transplantation for chronic myeloid leukemia. Impact of HLA class II matching. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation
    • Devergie A, Apperley JF, Labopin M et al. European results of matched unrelated donor bone marrow transplantation for chronic myeloid leukemia. Impact of HLA class II matching. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 1997; 20: 11-19.
    • (1997) Bone Marrow Transplant , vol.20 , pp. 11-19
    • Devergie, A.1    Apperley, J.F.2    Labopin, M.3
  • 170
    • 0018764352 scopus 로고
    • Antileukemic effect of graft-versus-host disease in recipients of allogeneic-marrow grafts
    • Weiden PL, Flournoy N, Thomas ED et al. Antileukemic effect of graft-versus-host disease in recipients of allogeneic-marrow grafts. N Engl J Med 1979; 300: 1068-73.
    • (1979) N Engl J Med , vol.300 , pp. 1068-1073
    • Weiden, P.L.1    Flournoy, N.2    Thomas, E.D.3
  • 171
    • 0024566585 scopus 로고
    • Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia
    • Sullivan KM, Weiden PL, Storb R et al. Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia. Blood 1989; 73: 1720-8.
    • (1989) Blood , vol.73 , pp. 1720-1728
    • Sullivan, K.M.1    Weiden, P.L.2    Storb, R.3
  • 172
    • 0025678601 scopus 로고
    • Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients
    • Kolb H, Mittermuller J, Clemm C et al. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 1990; 76: 2462-5.
    • (1990) Blood , vol.76 , pp. 2462-2465
    • Kolb, H.1    Mittermuller, J.2    Clemm, C.3
  • 173
    • 2942712161 scopus 로고    scopus 로고
    • Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation [see comments]
    • Collins RH Jr., Shpilberg O, Drobyski WR et al. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation [see comments]. J Clin Oncol 1997; 15: 433-44.
    • (1997) J Clin Oncol , vol.15 , pp. 433-444
    • Collins Jr., R.H.1    Shpilberg, O.2    Drobyski, W.R.3
  • 174
    • 0035883066 scopus 로고    scopus 로고
    • T cell depleted allogeneic bone marrow transplantation followed by donor lymphocyte infusion in patients with multiple myeloma: induction of graft versus myeloma effect
    • Alyea E, Weller E, Schlossman R et al. T cell depleted allogeneic bone marrow transplantation followed by donor lymphocyte infusion in patients with multiple myeloma: induction of graft versus myeloma effect. Blood 2001; 98: 934-9.
    • (2001) Blood , vol.98 , pp. 934-939
    • Alyea, E.1    Weller, E.2    Schlossman, R.3
  • 175
    • 28844483804 scopus 로고    scopus 로고
    • Autologous and allogeneic stem cell transplantations for poor-risk chronic lymphocytic leukemia
    • Gribben JG, Zahrieh D, Stephans K et al. Autologous and allogeneic stem cell transplantations for poor-risk chronic lymphocytic leukemia. Blood 2005; 106: 4389-96.
    • (2005) Blood , vol.106 , pp. 4389-4396
    • Gribben, J.G.1    Zahrieh, D.2    Stephans, K.3
  • 176
    • 0030896218 scopus 로고    scopus 로고
    • CD6-depleted allogeneic bone marrow transplantation for acute leukemia in first complete remission
    • Soiffer RJ, Fairclough D, Robertson M et al. CD6-depleted allogeneic bone marrow transplantation for acute leukemia in first complete remission. Blood 1997; 89: 3039-47.
    • (1997) Blood , vol.89 , pp. 3039-3047
    • Soiffer, R.J.1    Fairclough, D.2    Robertson, M.3
  • 177
    • 0029056848 scopus 로고
    • In vivo/ex vivo T cell depletion reduces the morbidity of allogeneic bone marrow transplantation in patients with acute leukaemias in first remission without increasing the risk of treatment failure: comparison with cyclosporine/methotrexate
    • Bunjes D, Hertenstein B, Wiesneth M et al. In vivo/ex vivo T cell depletion reduces the morbidity of allogeneic bone marrow transplantation in patients with acute leukaemias in first remission without increasing the risk of treatment failure: comparison with cyclosporine/methotrexate. Bone Marrow Transplant 1995; 15: 563-8.
    • (1995) Bone Marrow Transplant , vol.15 , pp. 563-568
    • Bunjes, D.1    Hertenstein, B.2    Wiesneth, M.3
  • 178
    • 0032005216 scopus 로고    scopus 로고
    • T-cell-depleted allogeneic bone marrow transplantation as postremission therapy for acute myelogenous leukemia: freedom from relapse in the absence of graft-versus-host disease
    • Papadopoulos EB, Carabasi MH, Castro-Malaspina H et al. T-cell-depleted allogeneic bone marrow transplantation as postremission therapy for acute myelogenous leukemia: freedom from relapse in the absence of graft-versus-host disease. Blood 1998; 91: 1083-90.
    • (1998) Blood , vol.91 , pp. 1083-1090
    • Papadopoulos, E.B.1    Carabasi, M.H.2    Castro-Malaspina, H.3
  • 179
    • 0028355980 scopus 로고
    • Longterm follow-up of a randomized trial comparing T-cell depletion with a combination of methotrexate and cyclosporine in adult leukemic marrow transplant recipients
    • Remberger M, Ringden O, Aschan J et al. Longterm follow-up of a randomized trial comparing T-cell depletion with a combination of methotrexate and cyclosporine in adult leukemic marrow transplant recipients. Transplant Proc 1994; 26: 1829-30.
    • (1994) Transplant Proc , vol.26 , pp. 1829-1830
    • Remberger, M.1    Ringden, O.2    Aschan, J.3
  • 180
    • 0027360966 scopus 로고    scopus 로고
    • Prediction of graft-versus-host disease by phenotypic analysis of early immune reconstitution after CD6-depleted allogeneic bone marrow transplantation
    • Soiffer RJ, Gonin R, Murray C et al. Prediction of graft-versus-host disease by phenotypic analysis of early immune reconstitution after CD6-depleted allogeneic bone marrow transplantation. Blood 2003; 82: 2216-23.
    • (2003) Blood , vol.82 , pp. 2216-2223
    • Soiffer, R.J.1    Gonin, R.2    Murray, C.3
  • 181
    • 6444245796 scopus 로고    scopus 로고
    • Randomized trial of CD8+ T-cell depletion in the prevention of graft-versus-host disease associated with donor lymphocyte infusion
    • Soiffer RJ, Alyea EP, Hochberg E et al. Randomized trial of CD8+ T-cell depletion in the prevention of graft-versus-host disease associated with donor lymphocyte infusion. Biol Blood Marrow Transplant 2002; 8: 625-32.
    • (2002) Biol Blood Marrow Transplant , vol.8 , pp. 625-632
    • Soiffer, R.J.1    Alyea, E.P.2    Hochberg, E.3
  • 182
    • 20244374668 scopus 로고    scopus 로고
    • Toxicity and efficacy of defined doses of CD4(+) donor lymphocytes for treatment of relapse after allogeneic bone marrow transplant
    • Alyea EP, Soiffer RJ, Canning C et al. Toxicity and efficacy of defined doses of CD4(+) donor lymphocytes for treatment of relapse after allogeneic bone marrow transplant. Blood 1998; 91: 3671-80.
    • (1998) Blood , vol.91 , pp. 3671-3680
    • Alyea, E.P.1    Soiffer, R.J.2    Canning, C.3
  • 183
    • 10044240333 scopus 로고    scopus 로고
    • Partial CD8+ T-cell depletion of allogeneic peripheral blood stem cell transplantation is insufficient to prevent graftversus-host disease
    • Ho VT, Kim HT, Li S et al. Partial CD8+ T-cell depletion of allogeneic peripheral blood stem cell transplantation is insufficient to prevent graftversus-host disease. Bone Marrow Transplant 2004; 34: 987-94.
    • (2004) Bone Marrow Transplant , vol.34 , pp. 987-994
    • Ho, V.T.1    Kim, H.T.2    Li, S.3
  • 184
    • 0033015210 scopus 로고    scopus 로고
    • Comparative outcomes of T-cell-depleted and non-Tcell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: impact of donor lymphocyte infusion
    • Sehn LH, Alyea EP, Weller E et al. Comparative outcomes of T-cell-depleted and non-Tcell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: impact of donor lymphocyte infusion. J Clin Oncol 1999; 17: 561-8.
    • (1999) J Clin Oncol , vol.17 , pp. 561-568
    • Sehn, L.H.1    Alyea, E.P.2    Weller, E.3
  • 185
    • 29844448554 scopus 로고    scopus 로고
    • Can only partial T-cell depletion of the graft before hematopoietic stem cell transplantation mitigate graft-versus-host disease while preserving a graftversus-leukemia reaction? A prospective phase II study
    • Chalandon Y, Roosnek E, Mermillod B et al. Can only partial T-cell depletion of the graft before hematopoietic stem cell transplantation mitigate graft-versus-host disease while preserving a graftversus-leukemia reaction? A prospective phase II study. Biol Blood Marrow Transplant 2006; 12: 102-10.
    • (2006) Biol Blood Marrow Transplant , vol.12 , pp. 102-110
    • Chalandon, Y.1    Roosnek, E.2    Mermillod, B.3
  • 186
    • 34548544801 scopus 로고    scopus 로고
    • Reducedintensity conditioning for allogeneic haematopoietic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: impact of alemtuzumab and donor lymphocyte infusions on longterm outcomes
    • Peggs KS, Sureda A, Qian W et al. Reducedintensity conditioning for allogeneic haematopoietic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: impact of alemtuzumab and donor lymphocyte infusions on longterm outcomes. Br J Hematol 2007; 139: 70-80.
    • (2007) Br J Hematol , vol.139 , pp. 70-80
    • Peggs, K.S.1    Sureda, A.2    Qian, W.3
  • 187
    • 0026512503 scopus 로고
    • Clinical and immunologic effects of prolonged infusion of low-dose recombinant interleukin-2 after autologous and T-cell-depleted allogeneic bone marrow transplantation
    • Soiffer RJ, Murray C, Cochran K et al. Clinical and immunologic effects of prolonged infusion of low-dose recombinant interleukin-2 after autologous and T-cell-depleted allogeneic bone marrow transplantation. Blood 1992; 79: 517-26.
    • (1992) Blood , vol.79 , pp. 517-526
    • Soiffer, R.J.1    Murray, C.2    Cochran, K.3
  • 188
    • 0028332772 scopus 로고
    • Effect of low-dose interleukin-2 on disease relapse after Tcell-depleted allogeneic bone marrow transplantation
    • Soiffer RJ, Murray C, Gonin R, Ritz J. Effect of low-dose interleukin-2 on disease relapse after Tcell-depleted allogeneic bone marrow transplantation. Blood 1994; 84: 961-74.
    • (1994) Blood , vol.84 , pp. 961-974
    • Soiffer, R.J.1    Murray, C.2    Gonin, R.3    Ritz, J.4
  • 189
    • 53649104968 scopus 로고    scopus 로고
    • Phase III trial of immunotherapy with recombinant interleukin-2 (rIL-2) versus observation in patients < 60 years with acute myeloid leukemia (AML) in first remission (CR1): preliminary results from Cancer and Leukemia Group B (CALGB) 19808
    • Abstract 157
    • Kolitz JE, Hars V, DeAngelo DJ et al. Phase III trial of immunotherapy with recombinant interleukin-2 (rIL-2) versus observation in patients < 60 years with acute myeloid leukemia (AML) in first remission (CR1): preliminary results from Cancer and Leukemia Group B (CALGB) 19808. American Society of Hematology Annual Meeting 2007; Abstract 157.
    • (2007) American Society of Hematology Annual Meeting
    • Kolitz, J.E.1    Hars, V.2    DeAngelo, D.J.3
  • 190
    • 0036566619 scopus 로고    scopus 로고
    • Prevention of graft-versus-host disease while preserving graftversus-leukemia effect after selective depletion of host-reactive T cells by photodynamic cell purging process
    • Chen BJ, Cui X, Liu C, Chao NJ. Prevention of graft-versus-host disease while preserving graftversus-leukemia effect after selective depletion of host-reactive T cells by photodynamic cell purging process. Blood 2002; 99: 3083-8.
    • (2002) Blood , vol.99 , pp. 3083-3088
    • Chen, B.J.1    Cui, X.2    Liu, C.3    Chao, N.J.4
  • 191
    • 0032968981 scopus 로고    scopus 로고
    • Selective removal of alloreactive cells from haematopoietic stem cell grafts: graft engineering for GVHD prophylaxis
    • Koh MB, Prentice HG, Lowdell MW. Selective removal of alloreactive cells from haematopoietic stem cell grafts: graft engineering for GVHD prophylaxis. Bone Marrow Transplant 1999; 23: 1071-9.
    • (1999) Bone Marrow Transplant , vol.23 , pp. 1071-1079
    • Koh, M.B.1    Prentice, H.G.2    Lowdell, M.W.3
  • 192
    • 21044431597 scopus 로고    scopus 로고
    • Selective depletion of alloreactive donor lymphocytes: a novel method to reduce the severity of graftversus-host disease in older patients undergoing matched sibling donor stem cell transplantation
    • Solomon SR, Mielke S, Savani BN et al. Selective depletion of alloreactive donor lymphocytes: a novel method to reduce the severity of graftversus-host disease in older patients undergoing matched sibling donor stem cell transplantation. Blood 2005; 106: 1123-9.
    • (2005) Blood , vol.106 , pp. 1123-1129
    • Solomon, S.R.1    Mielke, S.2    Savani, B.N.3
  • 193
    • 33644891348 scopus 로고    scopus 로고
    • A comparison of an anti-CD25 immunotoxin, Ontak and anti-CD25 microbeads for their ability to deplete alloreactive T cells in vitro
    • Vaclavkova P, Cao Y, Wu LK, Michalek J, Vitetta ES. A comparison of an anti-CD25 immunotoxin, Ontak and anti-CD25 microbeads for their ability to deplete alloreactive T cells in vitro. Bone Marrow Transplant 2006; 37: 559-67.
    • (2006) Bone Marrow Transplant , vol.37 , pp. 559-567
    • Vaclavkova, P.1    Cao, Y.2    Wu, L.K.3    Michalek, J.4    Vitetta, E.S.5
  • 194
    • 34247372624 scopus 로고    scopus 로고
    • Effective graft depletion of MiHAg T-cell specificities and consequences for graft-versus-host disease
    • De Witte MA, Toebes M, Song JY et al. Effective graft depletion of MiHAg T-cell specificities and consequences for graft-versus-host disease. Blood 2007; 109: 3830-8.
    • (2007) Blood , vol.109 , pp. 3830-3838
    • De Witte, M.A.1    Toebes, M.2    Song, J.Y.3
  • 195
    • 13544258633 scopus 로고    scopus 로고
    • Donor CD4+CD25+ T cells promote engraftment and tolerance following MHC-mismatched hematopoietic cell transplantation
    • Hanash AM, Levy RB. Donor CD4+CD25+ T cells promote engraftment and tolerance following MHC-mismatched hematopoietic cell transplantation. Blood 2005; 105: 1828-36.
    • (2005) Blood , vol.105 , pp. 1828-1836
    • Hanash, A.M.1    Levy, R.B.2
  • 196
    • 4644301368 scopus 로고    scopus 로고
    • Association of Foxp3 regulatory gene expression with graft-versus-host disease
    • Miura Y, Thoburn CJ, Bright EC et al. Association of Foxp3 regulatory gene expression with graft-versus-host disease. Blood 2004; 104: 2187-93.
    • (2004) Blood , vol.104 , pp. 2187-2193
    • Miura, Y.1    Thoburn, C.J.2    Bright, E.C.3
  • 197
    • 27144500976 scopus 로고    scopus 로고
    • Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease
    • Zorn E, Kim HT, Lee SJ et al. Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease. Blood 2005; 106: 2903-11.
    • (2005) Blood , vol.106 , pp. 2903-2911
    • Zorn, E.1    Kim, H.T.2    Lee, S.J.3
  • 198
    • 12144287816 scopus 로고    scopus 로고
    • Chronic graftversus-host disease is associated with increased numbers of peripheral blood CD4+CD25high regulatory T cells
    • Clark FJ, Gregg R, Piper K et al. Chronic graftversus-host disease is associated with increased numbers of peripheral blood CD4+CD25high regulatory T cells. Blood 2004; 103: 2410-16.
    • (2004) Blood , vol.103 , pp. 2410-2416
    • Clark, F.J.1    Gregg, R.2    Piper, K.3
  • 199
    • 3242801352 scopus 로고    scopus 로고
    • Large-scale in vitro expansion of polyclonal human CD4(+)CD25high regulatory T cells
    • Hoffmann P, Eder R, Kunz-Schughart LA et al. Large-scale in vitro expansion of polyclonal human CD4(+)CD25high regulatory T cells. Blood 2004; 104: 895-903.
    • (2004) Blood , vol.104 , pp. 895-903
    • Hoffmann, P.1    Eder, R.2    Kunz-Schughart, L.A.3
  • 200
    • 33747801470 scopus 로고    scopus 로고
    • IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo
    • Zorn E, Nelson EA, Mohseni M et al. IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo. Blood 2006; 108: 1571-9.
    • (2006) Blood , vol.108 , pp. 1571-1579
    • Zorn, E.1    Nelson, E.A.2    Mohseni, M.3
  • 201
    • 0033526011 scopus 로고    scopus 로고
    • Bone marrow NK1.1(-) and NK1.1(+) T cells reciprocally regulate acute graft versus host disease
    • Zeng D, Lewis D, Dejbakhsh-Jones S et al. Bone marrow NK1.1(-) and NK1.1(+) T cells reciprocally regulate acute graft versus host disease. J Exp Med 1999; 189: 1073-81.
    • (1999) J Exp Med , vol.189 , pp. 1073-1081
    • Zeng, D.1    Lewis, D.2    Dejbakhsh-Jones, S.3
  • 202
    • 0035881968 scopus 로고    scopus 로고
    • Predominance of NK1.1+TCR alpha beta+ or DX5+TCR alpha beta+ T cells in mice conditioned with fractionated lymphoid irradiation protects against graft-versus-host disease: "natural suppressor" cells
    • Lan F, Zeng D, Higuchi M, Huie P, Higgins JP, Strober S. Predominance of NK1.1+TCR alpha beta+ or DX5+TCR alpha beta+ T cells in mice conditioned with fractionated lymphoid irradiation protects against graft-versus-host disease: "natural suppressor" cells. J Immunol 2001; 167: 2087-96.
    • (2001) J Immunol , vol.167 , pp. 2087-2096
    • Lan, F.1    Zeng, D.2    Higuchi, M.3    Huie, P.4    Higgins, J.P.5    Strober, S.6
  • 203
    • 1542472609 scopus 로고    scopus 로고
    • Host conditioning with total lymphoid irradiation and antithymocyte globulin prevents graftversus-host disease: the role of CD1-reactive natural killer T cells
    • Lan F, Zeng D, Higuchi M, Higgins JP, Strober S. Host conditioning with total lymphoid irradiation and antithymocyte globulin prevents graftversus-host disease: the role of CD1-reactive natural killer T cells. Biol Blood Marrow Transplant 2003; 9: 355-63.
    • (2003) Biol Blood Marrow Transplant , vol.9 , pp. 355-363
    • Lan, F.1    Zeng, D.2    Higuchi, M.3    Higgins, J.P.4    Strober, S.5
  • 204
    • 25444461935 scopus 로고    scopus 로고
    • Protective conditioning for acute graft-versus-host disease
    • Lowsky R, Takahashi T, Liu YP et al. Protective conditioning for acute graft-versus-host disease. N Engl J Med 2005; 353: 1321-31.
    • (2005) N Engl J Med , vol.353 , pp. 1321-1331
    • Lowsky, R.1    Takahashi, T.2    Liu, Y.P.3
  • 205
    • 0031049485 scopus 로고    scopus 로고
    • Thymidine kinase (TK) gene-transduced human lymphocytes can be highly purified, remain fully functional, and are killed efficiently with ganciclovir
    • Munshi NC, Govindarajan R, Drake R et al. Thymidine kinase (TK) gene-transduced human lymphocytes can be highly purified, remain fully functional, and are killed efficiently with ganciclovir. Blood 1997; 89: 1334-40.
    • (1997) Blood , vol.89 , pp. 1334-1340
    • Munshi, N.C.1    Govindarajan, R.2    Drake, R.3
  • 206
    • 0035161228 scopus 로고    scopus 로고
    • Administration of herpes simplex-thymidine kinase-expressing donor T cells with a Tcell-depleted allogeneic marrow graft
    • Tiberghien P, Ferrand C, Lioure B et al. Administration of herpes simplex-thymidine kinase-expressing donor T cells with a Tcell-depleted allogeneic marrow graft. Blood 2001; 97: 63-72.
    • (2001) Blood , vol.97 , pp. 63-72
    • Tiberghien, P.1    Ferrand, C.2    Lioure, B.3
  • 207
    • 0034685197 scopus 로고    scopus 로고
    • Extensive vitiligo after ganciclovir treatment of GvHD in a patient who had received donor T cells expressing herpes simplex virus thymidine kinase
    • Aubin F, Cahn JY, Ferrand C et al. Extensive vitiligo after ganciclovir treatment of GvHD in a patient who had received donor T cells expressing herpes simplex virus thymidine kinase. Lancet 2000; 355: 626-7.
    • (2000) Lancet , vol.355 , pp. 626-627
    • Aubin, F.1    Cahn, J.Y.2    Ferrand, C.3
  • 208
    • 0031975258 scopus 로고    scopus 로고
    • Adoptive immunotherapy for leukemia: donor lymphocytes transduced with the herpes simplex thymidine kinase gene for remission induction. HGTRI 0103
    • Link CJ, Burt RK, Traynor AE et al. Adoptive immunotherapy for leukemia: donor lymphocytes transduced with the herpes simplex thymidine kinase gene for remission induction. HGTRI 0103. Hum Gene Ther 1998; 9: 115-34.
    • (1998) Hum Gene Ther , vol.9 , pp. 115-134
    • Link, C.J.1    Burt, R.K.2    Traynor, A.E.3
  • 209
    • 34249688206 scopus 로고    scopus 로고
    • Anti-tumor effects of HSV-TK engineered donor lymphocytes after allogeneic stem cell transplantation
    • Ciceri F, Bonini C, Marktel S et al. Anti-tumor effects of HSV-TK engineered donor lymphocytes after allogeneic stem cell transplantation. Blood 2007; 109: 4698-707.
    • (2007) Blood , vol.109 , pp. 4698-4707
    • Ciceri, F.1    Bonini, C.2    Marktel, S.3
  • 210
    • 34249748406 scopus 로고    scopus 로고
    • The potential immunogenicity of the TK suicide gene does not prevent full clinical benefit associated with the use of TK-transduced donor lymphocytes in HSCT for hematologic malignancies
    • Traversari C, Marktel S, Magnani Z et al. The potential immunogenicity of the TK suicide gene does not prevent full clinical benefit associated with the use of TK-transduced donor lymphocytes in HSCT for hematologic malignancies. Blood 2007; 109: 4708-15.
    • (2007) Blood , vol.109 , pp. 4708-4715
    • Traversari, C.1    Marktel, S.2    Magnani, Z.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.